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Abstract 
The hypothalamic-pituitary-adrenal (HPA) axis regulates the release of stress hormones 
and its function is dependent on various factors including prior exposure to stressors, 
circulating gonadal hormones, and developmental status. The overarching goal of this 
thesis was to uncover the potential mechanisms mediating developmental changes in 
HPA function and its regulation by gonadal hormones during adolescence and early 
adulthood. In Chapter 2, I found that pre-pubertal (postnatal day [P]35) and post-pubertal 
(P45) adolescents responded to an acute stressor with greater release of corticosterone 
(the main stress hormone in rodents) compared with adults (P75). To determine whether 
differences in corticosterone release were related to ongoing maturation of HPA 
feedback, I investigated glucocorticoid receptor (GR) activity and mRNA expression of 
receptors (Nr3c1, Nr3c2) and their co-chaperones (Fkbp5, Fkbp4, Bag1) in the 
hippocampus. I provide novel evidence that P35 males have more, not less, GR 
translocation from the cytosol to the nucleus in response to stress compared with P75 
males. Gene expression remained relatively stable across development, except for Fkbp4, 
which codes for a pro-translocation protein and was up-regulated in P35 males relative to 
expression in P75 males. Thus, there are developmental shifts in the hormonal response 
to stress that are likely unrelated to GR activity in the hippocampus. In Chapter 3, I 
investigated whether differences in HPA function are explained by gonadal status; in 
adult males, testosterone reduces HPA function. Age-related differences in corticosterone 
release persisted when orchiectomized (OCX) males at each age were administered 
testosterone. Moreover, the effect of testosterone changed across the adolescent period; 
relative to those that got blank implants, testosterone had no effect on post-stress 
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concentrations of corticosterone at P35, increased concentrations at P45, and tended to 
reduce concentrations at P75. Testosterone reduced expression of AVP in the PVN at all 
ages, but did not affect Fos (a marker of neuronal activation) expression. I hypothesized 
that the age-specific effects of testosterone on corticosterone were related to differential 
conversion to metabolites (e.g., estradiol), which I tested using androgen receptor (AR) 
and estrogen receptor (ER) antagonists (flutamide and tamoxifen, respectively) in the 
presence of testosterone or dihydrotestosterone (DHT). Testosterone produced a similar, 
albeit non-significant, age-specific pattern of effects on corticosterone as described 
above, and I found little evidence for effects of receptor antagonists. Androgens reduced 
post-stress concentrations of progesterone in all age groups, and flutamide prevented the 
effect. Together, this study provides evidence for developmental shifts in stress responses 
and their regulation by gonadal hormones. In Chapter 4, I examined the influence of 
estradiol on HPA function in adult female rats as a first step toward understanding 
developmental shifts. Ovariectomy (OVX) reduced post-stress concentrations of 
corticosterone compared with sham OVX and OVX females given estradiol alone or in 
combination with progesterone. I also found that OVX females had greater cytosolic 
expression of GR, possibly increasing sensitivity to corticosterone. In a second 
experiment, I found that progesterone partially mitigated the effect of estradiol on 
corticosterone release and that gene expression of stress hormone receptors (Nr3c1, 
Nr3c2), their co-chaperones (Fkbp5, Fkbp4, Bag1), and a co-activator (Src-1) did not 
change as a function of ovarian hormones. Together, these studies build on previous 
research investigating developmental and gonadal regulation of HPA activity and provide 
novel findings regarding potential mechanisms underlying their actions.  
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Chapter 1: General Introduction 
This chapter has been adapted from a published article: 
Green, M. R., & McCormick, C. M. (2016). Sex and stress steroids in adolescence: 
Gonadal regulation of the hypothalamic-pituitary-adrenal axis in the rat. General 
and Comparative Endocrinology, 234, 110-116. 
 
Author Contribution: I was responsible for writing the manuscript. Dr. Cheryl 
McCormick assisted with structuring and editing the manuscript.  
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Introduction 
Despite the diverse functions of the hypothalamic–pituitary–adrenal (HPA) axis, 
it is best known for its role in the stress response. When confronted with stressors, the 
HPA axis initiates a cascade of signaling that culminates in increased release of 
glucocorticoids from the adrenal glands, which helps an organism meet the demands of 
its environment (Sapolsky et al., 2000). Although acute activation of the HPA axis is 
adaptive, repeated or prolonged activation produces allostatic load and can have 
deleterious effects on physiology and function (Juster et al., 2010). There is much 
evidence for differences in HPA function from prenatal life to old age (Lupien et al., 
2009), and for sex differences in HPA function (Bangasser & Valentino, 2014; 
Panagiotakopoulos & Neigh, 2014). Relative to research efforts on the perinatal and adult 
periods of development, however, far less is known about the HPA axis during 
adolescence. Even less is known regarding the regulation of the HPA axis by the 
hypothalamic–pituitary–gonadal (HPG) axis during this time. In this review, we outline 
what is known from investigations in rats about how gonadal hormones organize and 
modulate HPA activity at different stages of development, and then focus on adolescence, 
highlighting the key outstanding questions regarding HPG–HPA interactions during that 
transitional time of life. Fig. 1-1 contains the key terms and abbreviations used in the 
review. 
HPA signaling 
The neuroendocrine stress response is initiated in the medial parvocellular portion 
of the paraventricular nucleus (PVN) of the hypothalamus. Excitatory input to the PVN is 
derived predominantly from ascending brainstem pathways that respond to physiological 
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challenges (e.g., ether inhalation and hypotension) and from limbic forebrain regions 
such as the amygdala, which activate the PVN through a multi-synaptic pathway during 
exposure to psychological challenges (e.g., restraint or conditioned fear) (Herman & 
Cullinan, 1997; Myers et al., 2014). The release of corticotropin releasing factor (CRF) 
and arginine vasopressin (AVP) into the hypophyseal portal veins to the anterior pituitary 
triggers the release of adrenocorticotropic hormone (ACTH) into general circulation, 
which then stimulates the synthesis and release of glucocorticoids (primarily 
corticosterone in rats) from the adrenal cortex. The release of glucocorticoids is regulated 
by a negative feedback system that operates at all levels of the axis as well as at upstream 
brain regions (notably, the hippocampus and medial prefrontal cortex), which dampen 
further HPA activation and promote a return to basal titers (Herman et al., 2005). In the 
absence of stressors, basal concentrations of glucocorticoids are lower and release from 
the adrenal cortex occurs in pulses (∼1 per hour). The extent of release is influenced by 
the circadian rhythm, with the peak and nadir corresponding to the beginning and end of 
the active phase each day, respectively. 
Glucocorticoids help an organism meet the demands of its environment by 
increasing energy metabolism by enhancing gluconeogenesis and glycolysis (reviewed in 
Sapolsky et al. 2000). Moreover, glucocorticoids can potentiate glucagon signaling and 
reduce insulin signaling, leading to greater release of glucose from the liver. During times 
of stress, greater glucose trafficking to the brain and muscles helps an organism cope 
with the challenge. Glucocorticoids released in response to threats will also constrain 
immune function and have anti-inflammatory activity, protecting an organism from 
overshooting an immune and HPA response (immune challenges activate HPA activity). 
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One means by which increased glucocorticoid signaling restricts immune function is by 
dampening lymphocyte production and the synthesis and release of cytokines. Not all 
actions of glucocorticoids involve stress-related concentrations, however, as resting 
concentrations have permissive roles on stress reactivity, such as enhancing the effects of 
catecholamines on increasing cardiovascular tone. When glucocorticoids are elevated 
(e.g., after stress), non-essential behaviours (e.g., reproduction and feeding) are inhibited, 
and the consolidation of emotionally-salient information is enhanced, which allows the 
organism to encode information necessary for survival and to make future predictions 
about potential environmental threats. 
The effects of glucocorticoids are mediated by mineralocorticoid receptors (MR) 
and glucocorticoid receptors (GR), ligand-activated transcription factors that reside 
mainly in the cytoplasm as part of a multimeric complex when unbound (Funder, 1997). 
Upon binding with glucocorticoids, the receptor translocates to the nucleus and forms a 
homodimer that binds to glucocorticoid response elements (GREs) in the promoter or 
intragenic region of GR-/MR-regulated genes, causing transactivation (reviewed 
in Ratman et al., 2013). Corticosteroid receptors can also cause transrepression by 
binding to a negative GRE or can alter gene expression at composite GREs or by 
tethering to other transcription factors (Ou et al., 2001; Biddie et al., 2011). The 
pleiotropic effect of corticosteroid receptors stems from the existence of multiple receptor 
isoforms, subtle differences in GRE sequences, cross-talk with other transcription factors, 
and the recruitment of various co-factors, to name a few (De Bosscher et al., 2008; 
Meijsing et al., 2009). GR and MR are also differentially expressed within the brain (MR 
mainly in limbic regions, GR more widespread) and possess different affinities for 
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corticosterone (5–10× higher affinity for MR than for GR) (Reul and De Kloet, 1985). 
Thus, GR binding is more sensitive to fluctuations in circulating concentrations of 
glucocorticoids, which leads to the hypothesis that MR predominantly affect basal 
function (e.g., maintain neuronal excitability, cardiovascular function, and circadian 
rhythm) and GR predominantly mediate stress effects (e.g., altered immune responses, 
negative feedback) (Gunnar & Quevedo, 2007). 
Sex differences in HPA function 
There are marked sex differences in HPA activity in rats. For example, basal titers 
of glucocorticoids are greater in females than males, and their comparable ACTH 
concentrations suggest that females have enhanced adrenal sensitivity (Atkinson and 
Waddell, 1997; Babb et al., 2013; Kitay, 1961; Seale et al., 2004a). In addition, relative 
to males, females have greater concentrations of ACTH and glucocorticoids after acute 
stress exposure and a slower return to baseline stress levels (Babb et al., 2013; Handa et 
al., 1994a; Iwasaki-Sekino et al., 2009; Seale et al., 2004a; Viau et al., 2005). Sex 
differences in PVN activation may underlie the greater stress-induced release of ACTH in 
females, as studies have shown that expression of the immediate early gene c-fos (marker 
of neural activation) is upregulated more in females than in males (Babb et al., 2013; 
Larkin et al., 2010), although others have reported no effect of sex (Viau et al., 2005) or a 
difference in the other direction (Sterrenburg et al., 2012; Zavala et al., 2011), variability 
that may be related to the time-points investigated after stress exposures. 
Sex-differences in ACTH release may also be mediated by differential expression 
of HPA-related genes in response to acute stress, with males typically expressing less 
CRF and AVP messenger RNA (mRNA) in the PVN and less of the ACTH precursor, 
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proopiomelanocortin (POMC), in the anterior pituitary compared with expression in 
females (Babb et al., 2013; Iwasaki-Sekino et al., 2009; Seale et al., 2004a; Viau et al., 
2005). Taken together, there is evidence of sex differences at each level of the HPA axis, 
with females typically showing a heightened neuroendocrine response. Nevertheless, 
females may be partially buffered from higher concentrations of glucocorticoids by their 
greater concentrations than males of corticosteroid binding globulin (CBG) in circulation 
(Gala and Westphal, 1965; McCormick et al., 2002), which limit the access of 
corticosterone to MR and GR (Henley and Lightman, 2011). 
Gonadal hormones modulate HPA function 
Sex differences in HPA function in adulthood involve, in part, activational effects 
of gonadal hormones (i.e., modulatory effects that depend on the concentrations of 
hormone in circulation). The majority of evidence derived from gonadectomy (GDX) and 
hormone replacement studies indicates that estrogens increase and androgens decrease 
HPA function (reviewed in Goel et al., 2014). For example, in females, GDX decreases 
post-stress concentrations of ACTH and corticosterone and causes a quicker return to 
basal stress levels, and treatment of estradiol reverses the dampening effects of GDX 
(Burgess and Handa, 1992; Kalil et al., 2013; Leśniewska et al., 1990; Lunga and 
Herbert, 2004; McCormick et al., 2002; Seale et al., 2004a,b; Viau and Meaney, 1991; 
Weiser and Handa, 2009). The stimulatory effects of estradiol are not always found, 
however, (see Babb et al., 2013; Larkin et al., 2010; Young et al., 2001), which may 
relate to duration and dosage of replacement. In males, GDX increases post-stress 
concentrations of ACTH and corticosterone and slows the return to basal titers, and 
androgen treatment typically reverses the effects of GDX (Handa et al., 1994b; 
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McCormick et al., 1998; Seale et al., 2004a, 2004b; Viau & Meaney, 1996, 2004; Viau et 
al., 2003). 
Effects of gonadal hormones are found at all levels of the HPA axis. For example, 
estradiol increases adrenal corticosterone content and sensitivity to ACTH, whereas 
androgens typically exert a dampening effect, contributing to the female-bias in basal and 
post-stress concentrations of corticosterone (Ajdžanović et al., 2015; Figueiredo et al., 
2007; Kitay, 1963; Leśniewska et al., 1990; Funder, 1997; Malendowicz and 
Mlynarczyk, 1982; Nowak et al., 1995). In the anterior pituitary, POMC mRNA was 
down-regulated by androgens in males and up-regulated by estradiol in females 
compared with GDX animals of the same sex when tested after an immune challenge 
(Seale et al., 2004b). Nevertheless, the effects of gonadal hormones on pituitary ACTH 
content are conflicting; some studies (Ajdžanović et al., 2015; Critchlow et al., 1963; 
Kitay, 1963), but not all (Leśniewska et al., 1990; Viau et al., 1999), have found 
androgens to decrease and estradiol to increase ACTH content. Gonadal hormones may 
modulate negative feedback in the pituitary, as estradiol reduced GR and MR binding and 
mRNA expression (Burgess and Handa, 1993; Peiffer and Barden, 1987; Turner, 1990) 
and, in males, androgens increased nuclear uptake of [3H] corticosterone, in vitro (Viau 
and Meaney, 2004), although evidence suggests that androgens do not affect MR and GR 
concentrations or binding, or pituitary sensitivity to CRF (Handa et al., 1994b; Viau and 
Meaney, 1996). 
The effects of estradiol on HPA-related gene and protein expression in the PVN 
are inconsistent in the literature. For example, estradiol increased stress-induced 
expression of c-fos mRNA in the PVN of males (Lund et al., 2004a, 2006), but in females 
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both excitatory (Larkin et al., 2010; Weiser and Handa, 2009) and inhibitory effects 
(Dayas et al., 2000; Figueiredo et al., 2007; Ter Horst et al., 2009) on c-fos expression 
have been reported. Further, estradiol augmented the stress-induced increase in CRF 
heteronuclear (hn) RNA in the PVN of males (Lund et al., 2004a), and, in females, 
estradiol increased basal and post-stress levels of CRF and AVP mRNA in some studies 
(Patchev et al., 1995; Seale et al., 2004b); others found no effect of gonadal hormones on 
one or more of these measures (Figueiredo et al., 2007; Lunga and Herbert, 2004; 
Paulmyer-Lacroix et al., 1996). There is some evidence, however, that estradiol may 
modulate CRF expression only during times of greater stimulation of the HPA axis by 
stressors (Goel et al., 2014; Lund et al., 2004a; Paulmyer-Lacroix et al., 1996). 
Two estrogen receptor isoforms, ERα and ERβ, were found to have opposing 
actions on HPA function (reviewed in Handa et al., 2008). Pylprazoletriol (PPT; binds 
with greater affinity to ERα than to ERβ) administered into the PVN mimicked the 
potentiating effects of estradiol on post-stress ACTH and corticosterone and on c-fos 
expression in the PVN in male and female rats, whereas an ERβ-selective agonist, 
diarylpropionitrile (DPN), had dampening effects (Liu et al., 2012; Lund et al., 2006; 
Weiser and Handa, 2009). Gene and protein expression of ERβ is found in the PVN, 
including the neuroendocrine cells of the medial parvocellular portion (∼5–15% co-
localize with CRF expression) (Laflamme et al., 1998; Shughrue and Merchenthaler, 
2001; Suzuki and Handa, 2005) and ERβ activation was found to influence CRF 
promoter activity (Miller et al., 2004), leading to the possibility of direct effects on the 
PVN (Handa and Weiser, 2014). In contrast, the PVN lacks ERα (Laflamme et al., 1998; 
Miller et al., 2004; Suzuki and Handa, 2005), thus, the ability of estradiol and PPT to 
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dampen negative feedback is likely mediated by actions on GABAergic neurons of the 
peri-PVN (Weiser and Handa, 2009). Actions of estradiol likely also occur upstream of 
the PVN in regions such as the bed nucleus of the stria terminalis (BST), medial preoptic 
area (MPOA), hippocampus, and amygdala, all of which express ERα and ERβ (Handa 
and Weiser, 2014). 
Androgens typically dampen PVN function in response to stress. In males, stress-
induced Fos expression was inversely correlated with plasma testosterone, and GDX 
increased and prolonged PVN activation (Viau et al., 2003). GDX had no effect on 
baseline expression of CRF and AVP hnRNA in the PVN of males, but their expression 
was increased after restraint stress, and AVP hnRNA was negatively correlated with 
plasma testosterone. Similar effects of GDX have been obtained for the expression of 
CRF and AVP mRNA after LPS administration, all of which was reversed with either 
testosterone or dihydrotestosterone (DHT; a more potent, non-aromatizable androgen) 
(Seale et al., 2004a, 2004b). DHT also reduced expression of c-fos mRNA and CRF and 
AVP hnRNA after exposure to restraint stress (Lund et al., 2004a, 2006) and recent 
research indicates that the dampening effects of testosterone implanted near the PVN 
requires the conversion of testosterone to DHT via 5α-reductase (Handa et al., 2013). 
Actions of androgens on PVN function likely occur outside of the PVN because 
its neuroendocrine cells are lacking in androgen receptors (AR) (Bingham et al., 2006; 
Handa and Weiser, 2014). The MPOA appears to be an important site for androgen’s 
effects; it is rich in AR, has functional connections to the PVN, and androgen 
replacement limited to the MPOA decreased AVP hnRNA in the PVN (Williamson et al., 
2010) and dampened corticosterone release (McCormick et al., 2002), whereas lesions of 
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the MPOA prevented the dampening effect (Viau and Meaney, 1996). Further, 
testosterone facilitated GR binding in the MPOA, but not in other stress-responsive 
regions (e.g., hypothalamus, pituitary, hippocampus, amygdala) (Viau and Meaney, 
1996). The effects of androgens in the posterior BST, however, seem to be opposite to 
that of the MPOA, as DHT increased Fos-ir and AVP mRNA in the PVN, effects that 
were blocked with co-administration of an AR antagonist (Bingham et al., 2011). 
The use of DHT and AR antagonists suggested that ARs mediated the suppressing effect 
of androgens; more recent work has demonstrated an alternative receptor, which would 
help to explain the effects of androgens administered directly to the PVN (Handa and 
Weiser, 2014). Although central actions may require conversion of testosterone to DHT, 
which too acts at AR, DHT can also be metabolized to 3β-diol, which can bind and 
activate ERβ, and thereby dampen stress-induced HPA activity (Lund et al., 2004b, 2006; 
Handa et al., 2011). 
Gonadal hormones in early life organize the HPA axis 
The extent of influence of the HPG axis on the HPA axis is determined in part by 
gonadal hormones in early-life (i.e., organizational/programming effects). Although 
gonadal function is relatively quiescent until puberty, males are exposed to two surges in 
testosterone release, one late in gestation and one soon after birth. Neonatal GDX or 
antagonism of testosterone’s actions at AR reduced male rats’ sensitivity to testosterone’s 
dampening effects on corticosterone release in response to stress in adulthood (Bingham 
and Viau, 2008; McCormick et al., 1998). Females given a single dose of testosterone as 
neonates also exhibited a dampened stress response as adults (Seale et al., 2005a). 
Testosterone’s organizational effects in the neonatal period involve both AR and ER 
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(through testosterone’s conversion to estradiol by aromatase); males treated with either 
an AR antagonist or an aromatase inhibitor during the perinatal period had increased 
basal and stress-induced concentrations of corticosterone in adulthood (Bingham et al., 
2011, 2012; McCormick and Mahoney, 1999; Seale et al. 2005b). 
In males, neonatal GDX increased MR binding and decreased GR binding in the 
adult anterior pituitary (McCormick et al., 1998) and both antagonism of AR and 
inhibition of aromatase reduced GR mRNA expression in the PVN (Seale et al., 2005b). 
In females, neonatal treatment of testosterone or estradiol increased adult expression of 
GR mRNA in the PVN (Patchev et al., 1995; Seale et al., 2005a). In the adult 
hippocampus, GR mRNA expression was lower in females administered estradiol as 
neonates (Patchev et al., 1995), although adult corticosteroid receptor mRNA expression 
in the hippocampus was unaffected by neonatal blockade of AR or aromatase inhibition 
in males (Seale et al., 2005b). Together, these findings suggest that perinatal androgen 
exposure and actions at AR and ER may enhance HPA negative feedback in adulthood in 
a region-specific manner. 
Androgen exposure in neonatal life reduced HPA drive in adulthood as evidenced 
by reduced neural activation in the PVN in response to stress (Bingham and Viau, 2008), 
and neonatal treatment with an aromatase inhibitor increased neural activation in various 
stress-responsive brain regions (e.g., PVN, lateral septum, amygdala) (Bingham et al., 
2012). Gene expression of CRF and AVP in the PVN as well as POMC in the anterior 
pituitary is also up-regulated in males given AR antagonists or aromatase inhibitors 
perinatally, whereas females given testosterone perinatally had down-regulated 
expression after stress in adulthood (Seale et al., 2005a, 2005b). In contrast, adult females 
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treated with estradiol as neonates had up-regulated CRF and AVP mRNA in the PVN 
(Patchev et al., 1995). Bingham and Viau (2008) found no effect of neonatal testosterone 
exposure on adult CRF and AVP mRNA in the PVN, but did see increased expression of 
AVP and AR in the BST and medial amygdala, providing further evidence that early 
androgen exposure in early-life modulates adult sensitivity to androgens. Moreover, the 
organizational effects of testosterone on AVP in the BST and medial amygdala are at 
least in part related to ER activation (Bingham et al., 2012; Han and De Vries, 2003). The 
divergent findings regarding adult expression of HPA-related genes in the PVN may be 
related to differences in the timing and duration of treatment in early-life. Nevertheless, 
the available evidence indicates that adult HPA function is shaped by perinatal gonadal 
hormones. 
Adolescence as a transitional period in HPG–HPA interactions 
Although there is no clear onset or offset, adolescence is broadly defined in 
rodents as postnatal day (P) 22 to P59, with markers of puberty occurring at about P35 in 
females and P42 in males, and P60 considered young adulthood (reviewed in McCormick 
and Green, 2013). Adolescence is characterized by marked shifts in behaviour, such as 
increased risk-taking, greater social interaction, and increased propensity for drugs of 
abuse (Doremus-Fitzwater et al., 2010). While some of these behaviours may be 
detrimental (e.g., greater sensitivity to alcohol) and a consequence of adaptive 
maturational processes, most are seen to prepare the organism for adult-life by promoting 
independence. Changes in behaviour reflect pronounced shifts in neuroendocrine function 
(e.g., HPG maturation associated with puberty) and neurobiology (e.g., changes in white 
matter, receptor densities, synaptic pruning, and neurogenesis) (Casey et al., 2008; He 
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and Crew, 2007; Varlinskaya et al., 2013). Developmental periods of heightened brain 
maturation (e.g., adolescence), may render the brain vulnerable to environmental 
influences. For example, the consequences of chronic stress are more long-lasting and 
detrimental when experienced in adolescence compared with in adulthood (Green and 
McCormick, 2013; McCormick and Green, 2013). Moreover, developmental changes in 
HPA activity during adolescence could be a contributing factor and thus, investigations 
into developmentally-related differences in HPA reactivity and downstream effects of 
stress signaling are important for elucidating markers of vulnerability or resilience. 
Basal titers of glucocorticoids increase until approximately P45, then stabilize at 
adult-typical levels (Pignatelli et al., 2006). Adrenal volume increases until ∼P60, but 
more so in females than in males (Pignatelli et al., 2006). In response to a variety of 
stressors, prepubertal rats of both sexes typically exhibit a more pronounced and slower 
to recover ACTH and corticosterone response compared to adults (Goldman et al., 1973; 
Hall and Romeo, 2013; Lui et al., 2012; Romeo et al., 2004a,b, 2006a,b; Vásquez and 
Akil, 1993). Greater HPA reactivity before puberty is likely attributable to a combination 
of factors such as maturing adrenal and pituitary function (Foilb et al., 2011; Lui et al., 
2012; Romeo et al., 2004b), greater stress-induced PVN activation (Lui et al., 2012; 
Romeo et al., 2006a; Viau et al., 2005), and developmental shifts in signaling upstream of 
the PVN (Weathington and Cooke, 2012). The prolonged corticosterone release of 
prepubertal rats may involve reduced negative feedback (Goldman et al., 1973; Vásquez 
and Akil, 1993), and some studies have found gene expression of corticosteroid receptors 
in the hippocampus to increase between P30 and adulthood (Bohn et al., 1994). 
Nevertheless, others have found GR expression in stress-related brain regions to remain
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stable (Dziedzic et al., 2014) or to decrease in adolescence (Meaney et al., 1985). Further, 
we have found comparable GR expression at P35, P45, and P75, but greater GR 
translocation in response to stress in adolescents than in adults (unpublished data)1; less 
translocation would be more consistent with reduced negative feedback. 
Adult-like function of the HPA axis emerges at ∼P60 (Foilb et al., 2011; Gomez 
et al., 2002). The developmental shift in HPA function is not explained by the low 
gonadal function in pre-pubertal adolescents relative to adults. When prepubertal males 
were GDX and provided adult titers of testosterone, they continued to display a 
protracted corticosterone response to restraint compared with similarly treated 
adults(Romeo et al., 2004a). AR antagonism had no effect on HPA function in P40 rats, 
but increased stress-induced ACTH release in adults (Gomez et al., 2004). HPA–HPG 
interactions change during adolescence in females as well; corticosterone remained 
elevated for longer after restraint in GDX prepubertal rats compared with GDX adult rats 
(Romeo et al., 2004b). Furthermore, estradiol treatment reduced the ACTH and 
corticosterone response to stress in prepubertal rats, in contrast to the enhancing effects 
observed in adulthood (Evuarherhe et al., 2009b). 
Outstanding questions for understanding HPG–HPA interactions in adolescence 
It is unclear why the HPA axis does not respond (in males) or responds differently 
(in females) to gonadal hormones before puberty. Androgens and estrogens are capable 
of modulating the expression of gonadal receptors and aromatase before puberty, as in 
adults (Lephart and Ojeda, 1990; Romeo et al., 2002). In the anterior hypothalamus, 
mRNA expression of AR, ERα, ERβ, and progesterone receptors (PR) is similar at P30
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and P60 (Walker et al., 2009), although age-related changes may exist in other regions; in 
the PVN of males, fewer cells express PR before puberty than in adulthood (Romeo et al., 
2005). It remains unclear, however, how progesterone activity modulates HPA function 
during the adolescent period, which is an important question considering that 
progesterone dampens HPA function in adulthood and that prepubertal rats secrete more 
progesterone in response to stress compared to adults (Romeo et al., 2005; Viau and 
Meaney, 1991). Evidence from our lab indicates that, in males, the progesterone response 
to stress does not mature until after puberty, as both P35 and P45 rats had a markedly 
greater response compared to young adults (unpublished data)2.  
Puberty-related shifts in HPA function may involve differential binding of 
hormones and their metabolites to gonadal receptors as well as to shifts in receptor 
function. Aromatase and 5α-reductase expression in the brain decreased in mid to late 
adolescence until reaching adult-typical levels (Ivanova and Beyer, 2000; Lephart et al., 
2001). Thus, treatment with gonadal hormones may result in differential conversion to 
various metabolites before puberty compared with in adulthood. Another possibility is 
that age-related differences in the effects of gonadal hormones are mediated by shifts in 
receptor chaperones and co-factors. For example, nuclear receptor activity modulates the 
expression of a variety of co-chaperones (e.g. FK506 binding protein 51 [Fkbp5] and 
peptidylprolyl isomerase D [Ppid]) that in turn modulate nuclear receptor activity 
(reviewed in Binder, 2009; Malviya et al., 2013). Nevertheless, whether the expression of 
proteins that modulate nuclear receptor activity changes in adolescence and whether 
gonadal hormones regulate the expression of these proteins in adolescence the way they 
do in adulthood is unknown. Age-difference in HPG–HPA interactions may also involve
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developmental shifts in co-factors that modulate the transcriptional effects of nuclear 
receptors; in mice, the expression of steroid receptor co-activators (SRC) changes in the 
hippocampus from P18 to adulthood (Schmidt et al., 2007) and in female rats, 
hypothalamic expression of SRC-1 changed throughout adolescence, but its gene 
expression was greatest at puberty (P40) (Mitev et al., 2003). 
A fundamental question to be answered is when in adolescence does the HPA axis 
become sensitive to regulation by the HPG axis. Investigations in postpubertal animals 
are lacking. We have evidence that the HPA axis of postpubertal adolescents (P45), in 
contrast to prepubertal adolescents (P35), is indeed sensitive to testosterone, but in 
adirection opposite to that of adults. Testosterone replacement increased, rather than 
decreased, corticosterone release in response to restraint stress in GDXed P45 males 
(unpublished observations)3. This effect may be related to developmental changes in 
enzymes that convert testosterone to estradiol and/or convert DHT to 3β-diol. 
Although there is limited evidence for HPG regulation of the HPA axis in 
prepubertal adolescence, there is some evidence that adolescence may be a second 
window for organizational effects of hormones on the HPA axis. Adult males were 
unresponsive to the dampening effects of testosterone treatment on corticosterone 
concentrations and on CRF and AVP mRNA in the PVN, if they were GDXed as 
prepubertal adolescents (Evuarherhe et al., 2009a). Prepubertal GDX, however, did not 
alter AR or ER expression in various HPA-related brain regions (Brown et al., 2015). In 
adolescence, testosterone altered the ongoing development of regions implicated in HPA 
activity (e.g., amygdala, MPOA) (reviewed in Schulz et al., 2009; Cooke and Shukla,
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2011). Nevertheless, some of the differences between adolescents and adults in HPA 
function may involve ongoing maturation of these structures.  
Lastly, evidence of a different regulation of the HPA axis by the HPG axis in 
adolescence than in adulthood begs the question of the functional significance of these 
changes. For example, there is a stress hyporesponsive period from approximately P2 to 
P12 in which many stressors are unable to activate the HPA axis, which has been 
postulated to protect ongoing brain development from elevations in glucocorticoids 
(Sapolsky and Meaney, 1986). The shifts in HPG regulation of the HPA axis may be 
relevant for other significant differences between adolescents and adults. Adolescence is 
a time of social restructuring, a critical period for social learning, and a time when social 
interactions have higher reward relative to in adulthood (reviewed in Doremus-Fitzwater 
et al., 2010). Is the differential function of the axes essential for the expression of the 
behavioral repertoire that is unique to the adolescent period of life? Do the shifts facilitate 
the secondary phase of sexual differentiation that occurs in adolescence? Understanding 
of HPG–HPA interactions in adolescence may be critical to understanding the heightened 
susceptibility of adolescents to the detrimental consequences of chronic stressors relative 
to adults (McCormick and Green, 2013; Romeo, 2013). 
Goals of the thesis4 
The above review of the literature provides the rationale for the questions 
addressed in my thesis, the overarching goal of which was to characterize and investigate 
the mechanisms underlying developmental shifts in HPA function and its regulation by 
gonadal hormones during adolescence and early adulthood. In Chapter 2, I characterized 
the hormonal profile (corticosterone, progesterone, testosterone) of male rats at baseline
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and in response to acute stress before, during, and after puberty. I then investigated 
whether age-related differences in stress responsivity involved changes in GR 
translocation and signaling in the hippocampus, by measuring GR expression in the 
cytosol and in the nucleus and gene expression of corticosteroid receptors and their co-
chaperones before and after stress. I provide novel evidence that age-related differences 
in the neuroendocrine function are unrelated to GR activity in the hippocampus and 
advance our general understanding of HPA maturation throughout adolescence. 
In Chapter 3, I examined whether developmental shifts in HPA function are 
related to changes in circulating gonadal hormones, which would provide a parsimonious 
explanation for age-related differences; in adult males, testosterone dampens HPA 
function and facilitates a return to baseline titers of corticosterone (Goel et al., 2014). 
Although a previous study found that age-related differences persisted when pre-pubertal 
adolescent males were given testosterone (Romeo et al., 2004a), the study involved small 
group sizes (n = 5 per group). Moreover, if testosterone could not regulate HPA 
responses prior to puberty, as reported by Romeo and colleagues (2004a), then it begs the 
question of how and when does HPA function become sensitive to gonadal regulation. 
Therefore, I examined the effects of testosterone on baseline and post-stress measures of 
HPA function (circulating corticosterone and PVN expression of Fos and AVP) at 
different ages. In general, I found evidence for developmental shifts in HPA function and 
in its regulation by gonadal hormones, which I hypothesized were related to differential 
conversion of testosterone to its metabolites based on previous evidence for 
developmental changes in central expression of aromatase and 5α-reductase between 
adolescence and adulthood (Lephart & Ojeda 1990). Because estradiol can increase stress 
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via ERα, and because DHT can dampen stress via AR or be metabolized into 3β-diol to 
have dampening effects via ERβ, I compared the effects of AR and ER antagonists to 
vehicle in OCX males treated with testosterone or DHT on post-stress release of 
corticosterone and progesterone. Together, these finding provide evidence that 
developmental shifts in HPA function are independent of gonadal status, and that gonadal 
regulation of HPA function changes during adolescence in a marker-specific manner. 
In Chapter 4, I investigated ovarian regulation of HPA function in adulthood. 
Previous research indicates that estradiol potentiates HPA responses and reduces negative 
feedback in both males and females, but the findings have not always been consistent. 
Moreover, evidence from cell culture studies indicates that estradiol’s actions may 
involve dampening of GR activity (Malviya et al., 2013). Therefore, I investigated the 
effects of OVX and of ovarian hormone replacement (estradiol alone or in combination 
with progesterone) in adulthood on corticosterone responses and hippocampal GR 
translocation and expression of certain genes of interest, which code for proteins involved 
in altering GR assembly, affinity, translocation, or transcriptional properties. The findings 
generated from this study clarify the effects of gonadal regulation of HPA function and 
provide evidence for underlying mechanisms mediating their effect. As such, these 
findings provide potential targets for future investigations into developmental changes in 
gonadal regulation of HPA function during adolescence in females. The results of these 
studies may also elucidate mechanisms that underscore the development of stress-related 
disorders (e.g., depression and anxiety), which typically emerge during adolescence in a 
sex-specific manner.  
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Figures 
 
Fig. 1-1. The figure includes a cartoon outline of a rat depicting relevant structures, a 
chart of the synthesis pathways of testosterone to estradiol and dihydrotestosterone 
(receptors for each metabolite are within parentheses; enzymes are italicized), key terms, 
and abbreviations used in the review (see Handa and Weiser, 2014 for discussion of the 
synthesis pathways). 
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Rationale for Chapter 2 
 In this chapter, I investigated the mechanisms underlying developmental shifts in 
HPA function. To do so, I first characterized the hormonal profile (corticosterone, 
progesterone, testosterone) of pre-pubertal and (P35) post-pubertal (P45) adolescent and 
adult (P75) male rats at baseline and in response to an acute stressor. I included post-
pubertal adolescents (P45), for which there are fewer investigations, to better understand 
the transition into adulthood in an age group that is undergoing marked hormonal 
changes. After I demonstrated developmental shifts in the hormonal profiles of male rats, 
I investigated GR signaling as a basis for age-related differences in HPA function, 
because previous research has provided evidenced for impaired negative feedback. To do 
so, I measured GR expression in the cytosolic and nuclear compartment of hippocampal 
tissue before and after acute restraint stress. I predicted that pre-pubertal males would 
have reduced translocation of GR from the cytosol to the nucleus in response to restraint 
stress. I also investigated age-related differences in mRNA expression corticosteroid 
receptors and their co-chaperones that modulate GR receptor assembly, binding affinity, 
and translocation as potential sources for differential GR activity. 
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Chapter 2: Glucocorticoid receptor translocation and expression of relevant genes 
in the hippocampus of adolescent and adult male rats. 
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Introduction 
The release of glucocorticoids (primarily corticosterone in rodents) is regulated by 
the hypothalamic-pituitary-adrenal (HPA) axis, which help individuals to meet the 
challenges of their environment by modulating glucose metabolism, cardiovascular 
function, immune function, and psychological processes (Sapolsky et al., 2000; 
Groeneweg et al., 2011). Actions of glucocorticoids are mediated predominantly by two 
intracellular receptors (mineralocorticoid and glucocorticoid receptors; MR and GR), 
which act as transcriptional regulators and differ in their distribution in the brain and in 
their affinities for glucocorticoids; at basal concentrations, unlike MR, GR are mostly 
unoccupied (Reul and de Kloet, 1985). Therefore, GR are more sensitive to stressor-
induced increases in glucocorticoid concentrations and are believed to mediate HPA 
feedback, whereby elevations in circulating glucocorticoid concentrations suppress 
further HPA activation, preventing over-exposure (Groeneweg et al., 2011; Herman et al., 
2012). 
Adolescence is a transitional stage of development that involves significant 
changes in the functioning of the HPA axis. In rodents, it is well-documented that pre-
pubertal adolescents have greater and more protracted corticosterone responses to 
stressors (e.g., restraint, ether exposure, foot shock) compared with responses found in 
early life (P1–14 days of age) and in adulthood (>P60 days of age) (Klein and Romeo, 
2013; Green and McCormick, 2016). The pronounced release of corticosterone in pre-
pubertal adolescent rats may be related to ongoing maturation at any level of the HPA 
axis. For example, the adrenals of pre-pubertal adolescents weigh more than those of 
adults after normalizing to total body weight, release more corticosterone in response to 
stressors, and differ in their response to exogenous adrenocorticotropic hormone (ACTH) 
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(Romeo et al., 2004a, 2005, 2014; Romeo, 2010; Foilb et al., 2011; Dziedzic et al., 2014; 
Hall and Romeo, 2014). Further, after exposure to a stressor, pre-pubertal rats have 
greater circulating concentrations of ACTH compared with adults (Romeo et al., 2006b; 
Foilb et al., 2011; Dziedzic et al., 2014; Hall and Romeo, 2014) and greater and/or more 
prolonged activation of the paraventricular nucleus (PVN) of the hypothalamus, as 
evidenced by increased expression of immediate early genes and their protein products 
(e.g., Fos and Egr-1) relative to adults (Viau et al., 2005; Lui et al., 2012; Hodges et al., 
2014), particularly in cells that are immunoreactive for corticotropin releasing factor 
(CRF) (Romeo et al., 2006a). There are also differences in gene expression of CRF and 
arginine vasopressin (AVP) in the PVN of pre-pubertal and adult rats, although the 
findings are somewhat inconsistent (Viau et al., 2005; Romeo et al., 2007). 
The exaggerated HPA reactivity that is evident in pre-pubertal males likely is 
unrelated to developmental changes in hypothalamic-pituitary-gonadal (HPG) function 
(onset of puberty occurs approximately at postnatal day [P] 34 in female rats and P42 in 
males) and in circulating gonadal hormones, which are known to affect the stress 
response in adults; estradiol increases and testosterone decreases HPA reactivity (Goel et 
al., 2014; Green and McCormick, 2016). Pre-pubertal males continued to show a greater 
and more prolonged release of ACTH and corticosterone compared with adults when 
males of both ages were gonadectomized and administered testosterone to mimic adult-
typical concentrations (Romeo et al., 2004a). The difference between pre-pubertal and 
adult females also persisted when both age groups were ovariectomized, suggesting that 
age-related differences in HPA function are not mediated by changes in ovarian 
hormones (Romeo et al., 2004b). Lastly, although post-pubertal adolescents (>∼P42 
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and <P60) have not been investigated to the same extent as pre-pubertal adolescents, the 
available evidence suggests that HPA function is still maturing during this time and into 
late adolescence (∼P50–P60) (Foilb et al., 2011; Hodges and McCormick, 2015). 
The exaggerated HPA reactivity and slower recovery in pre-pubertal males may 
be because HPA negative feedback is immature; administration of cortisol or the GR 
agonist dexamethasone was less effective at suppressing the hormonal response to 
stressors in pre-pubertal adolescents compared with in adults, which suggests ongoing 
maturation of HPA feedback during adolescence (Goldman et al., 1973; Vazquez and 
Akil, 1993). No differences were found, however, between adolescents and adults, in GR 
protein and gene expression in regions involved in HPA negative feedback (e.g., PVN, 
pituitary, hippocampus, and medial prefrontal cortex) in rodents (Vazquez, 1998; Romeo 
et al., 2008, 2013; Dziedzic et al., 2014). Nevertheless, there may be age-related 
differences in the affinity or activity of GR that cannot be seen by measuring overall 
expression.  
A related possibility is that changes during the adolescent period in the expression 
of co-chaperones involved in modulating GR activity are involved in age-related 
differences in HPA function. For example, FK506 binding protein 51 (Fkbp51, encoded 
by the FKBP5 gene) acts as a suppressor of GR activity by inhibiting the receptor’s 
ability to bind its ligand and translocate to the nucleus to affect gene expression (Binder, 
2009). Bag1 is thought to inhibit GR activity by interfering with the receptor’s assembly, 
by reducing receptor translocation, and by binding to the receptor’s hinge region and 
impeding DNA binding (Schmidt et al., 2003). In contrast, Fkbp52 (encoded by 
the FKBP4 gene) can be exchanged for Fkbp51 in the GR complex, and promotes 
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translocation into the nuclear compartment by recruiting the motor protein dynein 
(Davies et al., 2002). Furthermore many of the hormones that regulate chaperone 
expression (Hubler and Scammell, 2004; Binder, 2009; Malviya et al., 2013) increase in 
concentration during adolescence. 
In Experiment 1, we investigated age and stressor effects on hormone 
concentrations (corticosterone, testosterone, and progesterone) and on GR translocation 
in the hippocampus, a region that richly expresses corticosteroid receptors and is 
involved in negative feedback (Reul and de Kloet, 1985; Herman and Cullinan, 1997). 
Based on previous findings, we predicted that pre-pubertal adolescent males would have 
greater corticosterone and progesterone release in response to an acute stressor than 
would adults (Romeo et al., 2005, 2006b). Because pre-pubertal rats are postulated to 
have dampened feedback relative to adults (Goldman et al., 1973; Vazquez and Akil, 
1993), we also tested the hypothesis that prolonged corticosterone release in pre-pubertal 
adolescent rats involved reduced GR translocation from the cytoplasm to the nucleus 
after restraint stress. In Experiment 2 we investigated developmental and stressor-induced 
changes in the expression of genes that code for corticosteroid receptors and their 
chaperone proteins within the hippocampus (i.e., NR3C1, NR3C2, FKBP5, FKBP4, 
BAG1). In addition to investigating pre-pubertal adolescents (P35) and adults (P75), we 
investigated post-pubertal adolescents (P45) to gain insight into an age group for which 
less is known about HPA function to better understand the transition into adulthood. 
Methods 
Experiment 1 
Animals 
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For Experiment 1a, male Long-Evans rats were obtained at P30 (n = 32; 80–
115 g), P40 (n = 32; 180–220 grams), and P70 (n = 32; 300–385 g) from Charles River 
(St. Constant, Quebec) and housed in same-aged pairs. For Experiment 1b, a second 
batch of males arrived at P30 (n = 16; 100–130 g), P40 (n = 16; 175–215 g), and P70 
(n = 16; 300–355 g). Animals were given free access to food and water and kept on a 
12 h light-dark cycle (lights on at 09:00). All procedures were approved by the Brock 
University Animal Care and Use Committee and were in keeping with the National 
Institute of Health Guide for Care and Use of Laboratory Animals (Publication No. 85-
23, revised 1985) as well as the Canadian Council on Animal Care guidelines. 
Acute stressor procedure and sample collection 
The acute stressor procedure and sample collection began four to six days after 
the animals arrived at the facility, and thus were (±1 day) P35, P45, or P75 at collection. 
On each collection day, all age groups and time-points were represented. Within ∼2–5 h 
after lights on, rats were decapitated either directly from the home cage (baseline) or 
immediately after 30 min of restraint stress (post-restraint) in Plexiglas® restrainers 
(Experiment 1a), or after 30 min of recovery after the restraint stress (Experiment 1b), for 
the collection of trunk blood and brains. This range in time of day was chosen for the 
experiments so that samples were collected during the phase of the light cycle when basal 
plasma corticosterone concentrations and the percentage of bound GR are low; these 
conditions would better allow investigation of the effects of stress on GR translocation. 
Trunk blood was collected into ice-chilled glass tubes containing EDTA and centrifuged 
at 3000 RCF for 15 min. Plasma was collected and stored at −20° C until hormone assays 
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were conducted. Brains were quickly extracted, sliced into 1 mm thick sections on ice, 
and frozen on dry ice before stored at −80° C until further processed. 
Hormone assays 
Steroids were extracted from plasma using diethyl ether for the measurement of 
corticosterone, testosterone, and progesterone. All extracted samples were reconstituted 
in buffer provided in the enzyme-linked immunosorbent assay kits (Neogen, Lansing MI) 
and the assays were conducted according to the kit instructions and using a Biotech 
Synergy plate reader; all samples within an experiment were measured on the same day. 
Assay sensitivity was 0.05 ng/mL for corticosterone, 0.002 ng/mL for testosterone, and 
0.4 ng/mL for progesterone. 
Protein extraction and subcellular fractionation 
The whole hippocampus was dissected on dry ice and the tissue from two animals 
of the same age and time-point were pooled (∼100 mg of tissue per sample; n = 8 pooled 
samples for each age group at each of the baseline and post-restraint time points). 
Throughout the protein extraction, samples were kept on ice or at 4 °C. An appropriate 
volume of S1 buffer (10 mM HEPES pH 7.5, 1.5 mM MgCl2, 10 mM KCl, 2 mM DDT, 
1 mM EDTA, 1 mM EGTA, 0.5% Triton-X; with protease and phosphatase inhibitors 
[Roche]) was added to each sample, tissue was homogenized in a Bullet Blender®, and 
the homogenate was centrifuged (17200 RCF for 3 min), after which the supernatant 
(SN1) was collected for use as the cytosolic fraction and the pellet was retained for use as 
the nuclear fraction. SN1 was centrifuged (16000 RCF for 20 min) and the supernatant 
was collected for use as the final cytosolic fraction. The original nuclear pellet was 
washed by re-suspending it in S1 buffer using a 25 gauge needle and vortex, and then 
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was re-centrifuged (17200 RCF for 3 min). The supernatant was discarded and the 
washed pellet was re-suspended in an appropriate volume of S2 buffer (∼1.2 pellet 
volumes; 20 mM HEPES, 400 mM NaCl, 1.5 mM MgCl2, 0.1 mM EDTA, glycerol, 
2 mM DTT; with protease and phosphatase inhibitor [Roche]) using a 25 gauge needle, 
after which the samples incubated on ice for 1 h, with a vortex every 10 min. After 
incubation, the samples were centrifuged (17200 RCF for 30 min) and the supernatant 
was obtained for use as the final nuclear fraction. The amount of protein in the cytosolic 
and nuclear fractions was determined via the Bio-Rad Protein Assay procedure (Bio-Rad 
Laboratories). Samples were brought to an equal concentration using the appropriate 
buffer, and an equal volume of 2x Laemmli buffer was added. Samples were heated at 
70 °C for 3 min, centrifuged (16000 RCF for 10 min), and stored at −20 °C until use in 
Western blot experiments. 
Western blot 
To measure GR translocation, cytosolic and nuclear samples (30 μg of protein 
each) were resolved via SDS-PAGE on 7.5% polyacrylamide gels and transferred to a 
PVDF membrane (Millipore). Total protein was measured via Ponceau S stain and used 
to normalize GR values. Membranes were reactivated in methanol, washed (3 × 5 mins) 
in Tris-buffered saline with 1% Tween 20 (TBS-T), and blocked with 5% non-fat milk 
powder dissolved in TBS-T. Membranes incubated overnight at 4 °C in TBS-T 
containing 1% milk block and rabbit anti-GR (sc-1004, Santa Cruz; 1:500 and 1:200 for 
cytosolic and nuclear samples, respectively). The next day, membranes were washed, and 
then incubated for 45 min at room temperature in TBS-T containing 1% milk block and 
goat anti-rabbit (Alexa488, Life Technologies; 1:5000), washed again, and then were 
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imaged using a Bio-Rad VersaDoc (MP 4000). Each membrane included samples from 
each age and time-point (Experiment 1a) or each age (Experiment 1b). 
To validate the subcellular fractionation protocol, cytosolic and nuclear samples 
(10 μg of protein each) were resolved on 12.5% polyacrylamide gels, blocked with 5% 
BSA in TBS-T, and probed with rabbit anti-histone H3 (D1H2, Cell Signaling; 1:5000) 
and rabbit anti-GAPDH (14C10, Cell Signaling; 1:5000) in TBS-T with 1% BSA. The 
results indicated minimal contamination of the cytosolic and nuclear compartments and 
validated our fractionation (see Fig. 2-2A). 
Experiment 2 
Animals 
To measure gene expression, male Long Evans rats arrived at P29 (n = 16; 65–
90 g), P39 (n = 16; 125–205 g), and P69 (n = 16; 260–350 g). Animals were given free 
access to food and water and kept on a 12 h light-dark cycle (lights on at 09:00). All 
procedures were approved by the Brock University Animal Care and Use Committee and 
were in keeping with the National Institute of Health Guide for Care and Use of 
Laboratory Animals (Publication No. 85-23, revised 1985) as well as the Canadian 
Council on Animal Care guidelines. 
Acute stressor procedure and collection of brain tissues 
On P35, P45, or P75, animals were decapitated ∼3–5 h into the light phase either 
directly from the home-cage (baseline) or 90 min after 30 min of restraint stress (post-
restraint). The post-restraint time point was chosen to allow the time for changes in gene 
expression downstream of GR translocation, and adapted from Bourke et al. (2013). 
Brains were collected as described in Experiment 1. 
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RT-qPCR 
A total of eight 1 mm inner diameter punches from the dorsal and ventral 
hippocampus (2 punches per region and per hemisphere in 1 mm thick slices; ∼20 mg of 
tissue per sample) were collected on dry ice and total RNA was extracted using a Fatty 
Tissue RNA Purification Kit (Norgen, #36200) as per kit instructions. RNA 
concentration and quality was assessed using a Nanodrop and samples (500 ng of total 
RNA) were reverse transcribed using iScript cDNA Synthesis Kit (Bio-Rad Laboratories, 
# 1708891). Primers were designed to measure mRNA expression of various stress-
related genes (see Table 2-1). Samples were run in triplicate using CFX Connect Real-
Time System and SYBR green (Bio-Rad Laboratories) in a 96 well format and samples 
were counterbalanced within and across plates. Gene expression was normalized to 
Cyclophilin A and GAPDH, which demonstrated good target stability (mean CV = 0.06; 
mean M = 0.17) and showed no effect of age, of time-point, or interaction. Efficiencies 
were between 90 and 110% and no template controls (NTC) and no reverse transcriptase 
(NRT) controls indicated that there were no issues with primers and with genomic DNA 
contamination, respectively. 
Statistical analyses 
Experiments 1A and 2 involved 3 (age: P35, P45, P75) x 2 (time-point: baseline, 
post-restraint) between-subjects ANOVAs and Experiment 1b involved one-way (age: 
P35, P45, P75) ANOVAs. Because animals from Experiments 1a and 1b arrived in 
separate shipments from which samples were collected, dissected, processed, and tested 
separately, we did not make direct comparisons between the time-points in the two 
experiments. Alpha was set at p < 0.05 and significant interactions were followed-up with 
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independent samples t-tests (to compare the effect of time-point at each age) or with one-
way ANOVAs (to examine developmental changes at each time-point) and post hoc 
comparisons were Bonferroni corrected. For hormone concentrations and GR 
translocation (Experiments 1a and 1b) data analyses were conducted using SPSS 16. RT-
qPCR results (Experiment 2) were computed using the Bio-Rad CFX Manager and 
analyzed using GraphPad Prism 7. 
Results 
Experiment 1a 
Hormones 
Age-related differences in testosterone concentrations depended on time-point 
(F2,90 = 6.57, p = 0.002). At baseline (F2,45 = 6.98, p = 0.002), males at P35 had lower 
testosterone than did males at P45 and P75 (p = 0.003 and 0.022, respectively), which did 
not differ (p = 1.0). Post-restraint (F2,45 = 14.68, p < 0.001), males at P75 had greater 
concentrations than did males at P35 and P45 (p < 0.001 and p = 0.002, respectively), 
which did not differ (p = 0.320). Alternative analyses, performed to examine the effect of 
time-point on testosterone at each age, indicated that when compared with baseline, post-
restraint testosterone was lower in males at P35 (p = 0.037), did not differ at P45 
(p = 0.113), and was higher in males at P75 (p = 0.031; see Fig. 2-1A). 
For concentrations of progesterone, there was an interaction of age and time-point 
(F2,81 = 4.24, p = 0.018). At baseline (F2,38 = 3.30, p = 0.048), age-related differences 
were not significant after correction for pairwise comparisons, although there was a trend 
for P45 males to have greater concentrations of progesterone than P75 males (p = 0.080). 
Post-restraint (F2,43 = 6.33, p = 0.004), males at P35 and P45 had significantly greater 
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concentrations of progesterone than did males at P75 (ps = 0.008 and 0.012, respectively) 
and the two younger groups did not differ (p = 1.0; see Fig. 2-1B). 
The interaction between age and time-point was also significant for corticosterone 
concentrations (F2,90 = 5.66, p = 0.005). There were no age-related differences in 
concentrations of corticosterone at baseline (p = 0.409). Post-restraint 
(F2,45 = 5.97, p = 0.005), P35 males did not differ from P45 males (p = 0.385), and as 
predicted P35 males had greater concentrations than P75 males (p = 0.004). When one 
outlier (>−2 SD) in the P45 group was removed, their concentrations of corticosterone 
post-restraint were greater than P75 males, but the difference did not meet the criteria for 
statistical significance (p = 0.051; see Fig. 2-1C). 
Bivariate correlations were performed to examine the relationship of hormones at 
each age and time-point to see if the correlation found between progesterone and 
corticosterone in adults after exposure to a stressor (Hueston and Deak, 2014) is evident 
in adolescents. There were no significant correlations between hormones in rats of any 
age at baseline (ps > 0.05). Post-restraint, however, concentrations of corticosterone and 
progesterone were positively correlated at all three ages (P35, r = 0.63, p = 0.009; 
P45, r = 0.44, p = 0.089; P75, r = 0.78, p = 0.001), although the relationship failed to 
reach statistical significance in P45 males (see Fig. 2-1D). 
Glucocorticoid receptor translocation 
We measured GR expression in the cytosolic and nuclear fractions of 
hippocampal tissue collected at baseline and post-restraint. In cytosolic samples, there 
was no effect of age (p = 0.900) and, as predicted, there was an effect of time-point 
(F1,36 = 5.82, p = 0.021). Expression of GR in the cytosolic compartment was reduced 
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post-restraint (see Fig. 2-2B and 2-2D). For nuclear samples, there was a main effect of 
age and of time-point (p = 0.001 and p < 0.001, respectively), however, we investigated 
the interaction, which nearly reached statistical significance (F2,37 = 3.22, p = 0.051). 
There were no age-related differences observed at baseline (p = 0.125). Post-restraint 
(F2,17 = 5.76, p = 0.012), nuclear GR expression was greater in P35 males compared to 
P75 males (p = 0.011; see Fig. 2-2C and 2-2E), whereas expression in P45 males was 
intermediate and statistically did not differ from their younger or older comparisons 
(ps = 0.258 and 0.361, respectively). 
Experiment 1b 
Hormones 
Concentrations of testosterone 30 min post-restraint differed based on age 
(F2,44 = 32.74, p < 0.001). Specifically, males at P75 had greater concentrations of 
testosterone than did males at P35 and P45 (ps < 0.001), which did not differ (p = 0.65; 
see Fig. 2-3A). For progesterone, there was no longer an effect of age (p = 0.167; see Fig. 
2-3B) and all groups had returned to approximate baseline concentrations (∼1–3 ng/mL) 
as was seen in Experiment 1a (see Fig. 2-1B). For corticosterone, we predicted that 
adolescent males would have greater concentrations than adult males based on past 
findings. Similar to progesterone, however, concentrations of corticosterone had already 
returned to approximate baseline values (∼5–25 ng/mL), although there was an effect of 
age (F2,44 = 4.18, p = 0.022); P45 males had less circulating corticosterone than did P75 
males (p = 0.018), which did not differ from P35 males (p = 0.701; see Fig. 2-3C). There 
was no correlation between corticosterone and progesterone at any age after recovery, 
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whereas hormone concentrations were positively correlated immediately post-restraint 
(Experiment 1a). 
GR translocation 
Thirty minutes post-restraint, there were age-related differences in the expression 
of GR in the cytosolic (F2,19 = 6.06, p = 0.009) and nuclear (F2,19 = 4.48, p = 0.025) 
fractions in the hippocampus. In the cytosolic fraction, P35 males did not differ from P45 
males (p = 1.0) and had greater expression than did P75 males (p = 0.009). There was 
also a trend for P45 males to have greater expression of GR in the cytosol than P75 males 
(p = 0.078), but this did not reach statistical significance. Similar to our findings 
immediately post-restraint (Experiment 1a), there was greater expression of GR in the 
nuclear fraction in P35 males compared to P75 males (p = 0.028) and neither P35s nor 
P75s differed from P45 males (ps = 0.167 and 1.0, respectively; see Fig. 2-3D). 
Experiment 2 
RT-qPCR 
For the expression of NR3C1 (GR) mRNA in the hippocampus, there was no 
effect of age (p = 0.354), but there was a significant effect of time-point 
(F1,42 = 15.00, p < 0.001), which did not depend on age (p = 0.728); compared with 
baseline, NR3C1 expression was lower post-restraint (see Fig. 2-4A). For NR3C2 (MR) 
expression, there was no effect of age (p = 0.267), of time-point (p = 0.477), or 
interaction of the two (p = 0.460; see Fig. 2- 4B). We also measured the expression of 
receptor chaperones in the hippocampus and found that FKBP5 did not differ between the 
different age groups (p = 0.211), although there was a significant effect of time-point 
(F1,41 = 7.33, p = 0.010), which was independent of age (p = 0.931); compared with 
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baseline, FKBP5 expression was greater post-restraint (see Fig. 2-4C; note that one post-
restraint P35 sample was dropped from the analysis because it amplified inappropriately). 
In contrast, we did find a significant effect of age on the expression 
of FKBP4 (F2,42 = 4.39, p = 0.019) and relative to baseline, expression was increased 
post-restraint, although the difference failed to meet the criteria for statistical significance 
(F1,42 = 3.53, p = 0.067). There was no interaction of age and time-point 
on FKBP4 expression (p = 0.398). Post hoc comparisons indicated that, for FKBP4, P35 
males had greater expression than did P75 males (p = 0.019) and P45 males did not differ 
from either age group (ps = 0.132 and 1.0, respectively; see Fig. 2-4D). For the 
expression of Bag1, there was no effect of age (p = 0.247), nor of time-point (p = 0.577), 
nor was there an interaction of the two factors (p = 0.839; see Fig. 2-4E). 
Discussion 
We investigated age-related differences in HPA function by comparing pre-
pubertal and post- pubertal adolescents with adult males on neuroendocrine function and 
on GR translocation in response to an acute stressor. We also assessed mRNA expression 
for corticosteroid receptors (GR and MR) and receptor chaperones (Fkbp51, Fkbp52 and 
Bag1), which are known to modulate GR activity. The data indicated that, during the 
adolescent period, there are marked developmental shifts in the stressor-induced release 
of hormones (i.e., progesterone, corticosterone, and testosterone) and in GR translocation, 
which were likely unrelated to chaperones, as we found little evidence for developmental 
shifts in their expression. 
Based on previous research, we predicted that pre-pubertal adolescents would 
have an exaggerated and prolonged corticosterone response to an acute stressor compared 
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with that of adults (Goldman et al., 1973; Vazquez and Akil, 1993; Romeo et al., 2004a, 
2006b, 2014; Lui et al., 2012; Hall and Romeo, 2014). Consistent with our prediction and 
the literature, we found that P35 males had greater post-stress concentrations of 
corticosterone compared with P75 males. In post-pubertal adolescent rats (P45), for 
which less is known about HPA function, concentrations after restraint stress were 
intermediate to those of pre-pubertal adolescent and adult rats. We did not find evidence 
of a protracted corticosterone response in adolescent rats, however; concentrations of 
corticosterone had returned to basal titers (∼5–25 ng/mL) after 30 min of recovery, which 
suggests efficient HPA feedback in all three age groups. 
Concentrations of progesterone after restraint stress were markedly higher in both 
groups of adolescent rats compared with adult rats, which is consistent with what was 
found in pre-pubertal adolescents compared with adults (Romeo et al., 2004b, 2005, 
2006b). Age-related differences in the release of progesterone in response to a stressor 
are not related to gonadal status based on several lines of evidence. Firstly, in the present 
study P45 males had greater post-stress concentrations of progesterone despite having 
adult-like concentrations of testosterone at baseline. Secondly, both pre-pubertal males 
and females had greater stressor-induced release of progesterone and corticosterone 
compared with that of adults when rats of both ages were gonadectomized (Romeo et al., 
2004a,b, 2005), thus ruling out circulating gonadal hormones as an explanation for age-
related differences. Instead, adolescent shifts in progesterone and corticosterone 
responses to stress may be related to ongoing adrenocortical development, as 
adrenalectomy blocks the stress-induced increase in their release (Hueston and Deak, 
2014). Previous studies have shown that, compared with adults, pre-pubertal adolescents 
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have larger adrenals after normalizing to body weight and have elevated mRNA 
expression of the melanocortin 2 receptor, which may confer greater sensitivity to ACTH 
(Foilb et al., 2011; Lui et al., 2012; Romeo et al., 2014). Also, our findings that 
progesterone and corticosterone were positively correlated in all age groups after stress is 
consistent with what has been reported in adult male rats and is explained by the fact that 
ACTH acts as a secretagogue of both hormones (Hueston and Deak, 2014). Nevertheless, 
developmental changes in adrenal function cannot fully account for the exaggerated 
stress responses of pre-pubertal adolescents given that ACTH release (Romeo et al., 
2004a, 2006a,b; Hall and Romeo, 2014) and PVN activation are also more pronounced in 
response to a stressor in adolescents compared with adults (Romeo et al., 2006a; Hodges 
et al., 2014).  
Little is known about the function of progesterone release in response to a 
stressor; there is some evidence that progesterone dampens HPA function and reduces 
anxiety- and depressive-like behaviour (Viau and Meaney, 1991; Frye, 2011; Schiller et 
al., 2014). The implications of age-related differences in stressor-induced progesterone 
release on physiology and behaviour are unknown, but warrant investigation. 
Progesterone can competitively bind to GR and MR and act as a partial agonist 
(Rousseau et al., 1972; Rupprecht et al., 1993), and GR and progesterone receptors have 
both common and unique binding sites on DNA (Hubler and Scammell, 2004). 
In addition to finding age-related differences in baseline testosterone (pre-pubertal 
adolescent males had lower concentrations than did post-pubertal adolescents and adults), 
the effect of stress on the release of testosterone differed by age; stress decreased 
testosterone concentrations in adolescents and increased concentrations in adults. These 
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findings are consistent with reports that acute stress increased testosterone concentrations 
in adults (Armario and Castellanos, 1984; Romeo et al., 2004a; Foilb et al., 2011; Bourke 
et al., 2013; Hodges et al., 2014), and decreased concentrations in pre-pubertal 
adolescents (Romeo et al., 2004a; Foilb et al., 2011), and our research extends the results 
to post-pubertal adolescents. Further, acute stress has been shown to increase plasma 
concentrations of testosterone in adult baboons (Sapolsky, 1986) and humans (Girdler et 
al., 1997), and in juvenile, pubertal, and adult birds (Heiblum et al., 2000); thus the 
dampening effect of stress on testosterone in adolescents may be specific to rats. It is 
unclear why adolescent rats have lower concentrations of testosterone after stress, but 
others have speculated that there may be an initial release of testosterone that triggers a 
subsequent reduction in adolescent rats because of heightened feedback during this 
developmental window (Klein and Romeo, 2013). Although evidence suggests that 
stressors begin to increase testosterone release at approximately 50 days of age (Foilb et 
al., 2011), the molecular mechanisms that underlie shifts in HPA and HPG interactions 
(i.e., stressor effects on testosterone, and testosterone effects on stress responses) from 
that found in adolescence to that found in adulthood are unknown. 
Previous reports that adolescent rats have immature HPA negative feedback 
(Goldman et al., 1973; Vazquez and Akil, 1993) led us to investigate GR activity in the 
hippocampus, although we found that rats of all ages had recovered by 30 min after the 
stressor. Nevertheless, others have speculated that GR translocation is different in pre-
pubertal adolescents compared with adult rats (Dziedzic et al., 2014). We selected the 
hippocampus because it richly expresses corticosteroid receptors and is involved in 
regulating HPA function (Herman et al., 2012), and the involvement of the hippocampus 
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in HPA feedback is mediated in part by classical GR actions (Feldman and Weidenfeld, 
1999; Furay et al., 2008). Furthermore, there is some evidence of age-related differences 
in translocation; when dexamethasone was injected into the hippocampus of young adult 
rats, GR translocation increased and basal plasma corticosterone decreased, but in aged 
rats, dexamethasone administration did not induce translocation, nor did it reduce 
corticosterone (Mizoguchi et al., 2009). 
Although others have reported no age-related difference in GR expression 
(Dziedzic et al., 2014; Romeo et al., 2008), they had not investigated cytosolic and 
nuclear GR separately. We did not find age-related differences in baseline expression of 
GR in the hippocampus within the cellular compartments examined (i.e., cytosolic and 
nuclear). We did, however, find evidence of GR translocation in that restraint stress 
decreased receptor expression in the cytosol and increased expression in the nucleus, and 
the magnitude of change depended on age. Contrary to expectations, pre-pubertal 
adolescent males had more GR translocation compared with that of adults as indicated by 
greater expression of nuclear GR immediately after restraint stress, which corresponded 
with, and likely reflected, the observed age-related difference in the release of 
corticosterone. Consistent with this interpretation, as was found for plasma corticosterone 
concentrations, GR translocation in post-pubertal adolescents was intermediate to that of 
pre-pubertal adolescents and adults. Further, age-related differences in the release of 
progesterone in response to a stressor may have contributed to the age-related difference 
observed in GR translocation, as progesterone has been shown to bind GR and trigger 
translocation (Rupprecht et al., 1993; Peeters et al., 2008). Unlike in the nuclear fraction 
of hippocampal tissue, we did not find an age-related difference in GR expression in the 
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cytosol. Nevertheless, the change from baseline to post-restraint appeared to be more 
pronounced in P35 males than in P45 and P75 males (Fig. 2-2B and 2-2D), consistent 
with what was seen in the nucleus (Fig. 2-2C and 2-2E), and the lack of a significant 
interaction is likely related to small group sizes and reduced sensitivity to detect an effect 
of stress in the cytosol relative to that seen in the nucleus. A question that remains is why 
P35 males had elevated GR expression in both the cytosolic and nuclear fractions 30 min 
after cessation of the stressor compared with that of adults. One possibility is that the 
greater expression in the nucleus reflects persistent age-related difference in 
translocation, whereas differences in total (nuclear and cytosolic) GR may be related to 
age-related differences in protein degradation after a stressor. Future studies could assess 
developmental shifts in degradation by measuring GR translocation after a stressor in the 
presence of a proteasome inhibitor. 
Because we had predicted age-related differences in GR translocation, we 
investigated mRNA expression of chaperones that modulate GR signaling (i.e., FKBP5, 
FKBP4, BAG1) as well as mRNA expression of corticosteroid receptors (i.e., NR3C1 and 
NR3C2). Only the expression of FKBP4 (codes for Fkbpp52, a pro-translocation 
chaperone) differed as a function of age and in the direction opposite of what we had 
predicted; we found that pre-pubertal adolescents had greater expression than adults. 
Nevertheless, this may provide correlational evidence of why adolescents had more, not 
less, translocation relative to that of adults, although future studies are needed to identify 
Fkbp52 as a mechanism. Independent of age, stress altered the expression of several 
genes of interest in the hippocampus including NR3C1 (GR), which was down-regulated 
in all age groups 90 min after termination of restraint, consistent with findings in the 
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literature that stress decreases its expression in the hippocampus of adults (Herman, 
1993; Romeo et al., 2008; Noguchi et al., 2010) and of pre-pubertal adolescents (Romeo 
et al., 2008). Further, we found that stress up-regulated FKBP5 mRNA, consistent with 
the previous reports in rats (Bourke et al., 2013), mice (Scharf et al., 2011), or via 
application of glucocorticoids in cell culture (Vermeer et al., 2003). The stress-induced 
increase in FKBP5 may represent an ‘ultra-short negative feedback loop’ given that it 
reduces GR’s affinity for glucocorticoids and ability to translocate into the nucleus 
(Binder, 2009). 
In sum, pre-pubertal adolescents had greater HPA responses and GR translocation 
than did adults despite equal effects of stress at both ages on NR3C1 and FKBP5 mRNA, 
which suggests that there are age-related differences in their regulation by stress. The 
lack of an age-related difference in mRNA expression post-restraint is surprising based 
on the differences in corticosterone and GR translocation, because previous studies 
reported that changes in mRNA expression are related to the extent of corticosterone 
release; the expression of NR3C1 in the hippocampus of adrenalectomized rats (Hugin-
Flores et al., 2004) and FKBP5 in cell culture (Vermeer et al., 2003) is dose-dependently 
regulated after treatment with a GR agonist. There are many factors that might contribute 
to age-related differences in GR activity inside the nucleus. For example, there may be 
age-related differences in co-factors (e.g., GR interacting protein [GRIP1] or steroid 
receptor co-activator 1 [SRC-1]) that modulate GR activity inside the nucleus; expression 
of SRC-1 was shown to change across the adolescent period in the female rat brain and is 
modulated by gonadal hormones (Mitev et al., 2003). Alternatively, greater release of 
progesterone in adolescent rats may have resulted in differential transcriptional properties 
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of GR, as progesterone induces GR translocation without having the same transcriptional 
properties as that of GR bound to glucocorticoids (Rupprecht et al., 1993). 
One limitation of the experiments is that rats were shipped from a commercial 
supplier, and the effects of shipping stress in rats may be age-specific. We did not find 
differences in baseline corticosterone across the age groups, which may indicate that 
shipping stress did not produce any age-specific lasting effect on the HPA axis. In 
addition, others have reported that age-related differences in HPA responses to stressors 
did not depend on whether the rats were shipped or obtained in-house (Lui et al., 2012). 
Nevertheless, we cannot rule out an effect of shipping stress from our results. 
In conclusion, neuroendocrine responses to acute stressors change significantly 
during the adolescent period. Despite increased gonadal function, the post-pubertal 
adolescent’s responding resembles more that of pre-pubertal adolescents than adults. The 
greater stressor-induced GR translocation in pre-pubertal adolescents may contribute to 
the enhanced sensitivity of adolescent rats to the effects of chronic stress exposures 
compared with adults (McCormick and Green, 2013). 
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Tables 
Table 2-1. Sequences of primers used in RT-qPCR reactions. 
Gene Forward primer Reverse Primer 
NR3C1 (GR) GTGCTACCCCGACAGAGAAG CCGCCAAAGGAGAAAGCAAG 
NR3C2 (MR) CAGCTCACCTCCATTACGCA CTTCACGACCTGGCTCATCT 
FKBP5 TTCCCTCGAACGCAACTCTC GTCGTGGTCTTCTCCTTCGC 
FKBP4 GAAGTCGGGGAAGGGGAAAG GCATGTGGTGGGATCTGGAA 
BAG1 TAGCGGAAGAGGTGACCCAG CTCCTGTGGCCTCTTCAACA 
Cyclophilin A CCGCTGTCTCTTTTCGCC ATCCTTTCTCCCCAGTGCTC 
GAPDH GGAAGCTGGTCATCAACGGG CGGAGATGATGACCCTTTTGG 
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Figures  
 
Fig. 2-1. Mean (±S.E.M.) plasma hormone concentrations of (A) testosterone, (B) 
progesterone, and (C) corticosterone immediately before (baseline) and after (post-
restraint) 30 min of restraint stress in P35, P45, and P75 male rats. (D) Depicts a positive 
correlation between plasma corticosterone and progesterone post-restraint in male rats at 
P35 (r = 0.63), P45 (r = 0.44), and P75 (r = 0.78). Different lowercase letters denote 
significant differences between ages in baseline concentrations (p < 0.05). Different 
uppercase letters denote significant differences between ages in post-restraint 
concentrations (p < 0.05). 
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Fig. 2-2. (A) Representative Western blot demonstrating successful isolation of cytosolic 
and nuclear fractions in hippocampal tissue using anti-GAPDH and anti-H3 antibodies, 
respectively. Representative Western blot of GR protein expression in the (B) cytosolic 
and (C) nuclear fractions. Mean (±S.E.M.) expression of GR protein in the (D) cytosolic 
and (E) nuclear fractions immediately before (baseline) and after (post-restraint) 30 min 
of restraint stress in P35, P45, and P75 male rats. All data are expressed in arbitrary units. 
Different uppercase letters denote significant age-related differences post-restraint and an 
asterisk indicates a significant main effect of time-point (p < 0.05). 
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Fig. 2-3. Mean (±S.E.M.) plasma hormone concentrations of (A) testosterone, (B) 
progesterone, and (C) corticosterone 30 min after the cessation of restraint stress in P35, 
P45, and P75 male rats. (D) Mean (±S.E.M.) expression of cytosolic and nuclear GR 
protein 30 min after the cessation of stress in P35, P45, and P75 male rats. Different 
lower case letters denote significant age-related differences (p < 0.05). 
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Fig. 2-4. Mean (±S.E.M.) mRNA expression of (A) GR, (B) MR, (C) FKBP5, 
(D) FKBP4, and (E) BAG1 immediately before (baseline) and 90 min after (post-
restraint) 30 min of restraint stress in P35, P45, and P75 male rats. Data are expressed as 
fold change relative to baseline P75 rats. An asterisk denotes a significant main effect of 
time-point and a number sign denotes significant difference between ages (p < 0.05). 
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Rationale for Chapter 3 
In chapter 2, I provided evidence of developmental shifts in HPA function; pre-
pubertal and post-pubertal adolescent males had greater release of corticosterone and 
progesterone in response to restraint stress than did adult males. I also showed that these 
differences were not likely related to differential GR-mediated negative feedback in the 
hippocampus or expression of co-chaperones known to modulate GR activity. An 
alternative possibility is that age-related differences in HPA responses are related to 
changes in circulating gonadal hormones. In adult males, androgens reduce HPA 
responses to stress and facilitate a return to baseline concentrations of corticosterone 
(Green & McCormick, 2016). Therefore, pre-pubertal males may respond more strongly, 
because adults have markedly higher concentrations of circulating testosterone. One 
previous study addressed this question and found that the age-related differences 
persisted when both age groups were OCXed and given a testosterone implant (Romeo et 
al., 2004). Therefore, in the next chapter, I sought to replicate this study and further 
investigate gonadal status as a source of age-related differences in HPA reactivity.  
If testosterone cannot make the pre-pubertal HPA response adult-like, then this 
suggests that males at this age are unresponsive to the dampening effects of testosterone, 
and begs the question of when does the HPA axis become sensitive to gonadal hormones. 
In this chapter, I compare the effects of a testosterone implant (versus those given a blank 
implant) at different ages to examine developmental shifts in HPA regulation by gonadal 
hormones. In addition to measuring corticosterone concentrations (the main output of the 
HPA axis), I examined Fos and AVP expression in the PVN, where the hormonal stress 
response is initiated. Fos is a marker of neuronal activation and AVP is a co-
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sectretagogue of ACTH, which triggers the release of corticosterone from the adrenals. In 
adults, both Fos and AVP are dampened by testosterone (Goel et al., 2014). 
In this chapter, I also conduct a second experiment to replicate and extend the 
findings from experiment 1; we found that the effects of testosterone were different at 
each age examined. Actions of testosterone are mainly attributed to activation of 
androgen receptors (AR); however, testosterone can also be converted to estradiol or to 
DHT, which can be further converted to 3β-diol. In adult males, estradiol increases HPA 
function by binding to estrogen receptor α (ERα), whereas DHT and 3β-diol reduce HPA 
function by binding to AR or estrogen receptor β (ERβ), respectively (Handa & Weiser, 
2014). Therefore, age-specific effects of testosterone on HPA function may be related to 
developmental changes in enzymes that regulate testosterone conversion. To tease apart 
the contributions of receptor targets on modulating HPA function in the three age groups, 
I examine the effects of AR and ER antagonism (versus vehicle) in OCX males that 
received testosterone or DHT on concentrations of corticosterone after exposure to an 
acute stressor.  
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Chapter 3: The effects of gonadal hormones on HPA function change throughout 
adolescence and do not account for developmental shifts in stress reactivity. 
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Introduction 
 Developmental changes in hypothalamic-pituitary-adrenal (HPA) function during 
adolescence have been well documented in rodents (Romeo, 2013; Green & McCormick, 
2016). Pre-pubertal adolescents respond to an acute stressor with a more pronounced 
release of adrenocorticotropic hormone (ACTH) and corticosterone than do adults. 
Moreover, concentrations remain elevated for longer in pre-pubertal males, despite 
similar rates of hormone metabolism (Schapiro, Percin, & Kotichas, 1971; Vazquez, 
1998), which suggests that negative feedback is maturing during adolescence (Green & 
McCormick, 2016; Romeo, 2013). The underlying mechanisms that mediate 
developmental shifts in HPA function, however, remain somewhat unclear and may be 
related to actions at each level of the HPA axis. 
 Relative to total body weight, the adrenal glands of pre-pubertal adolescents are 
larger than that of adults and may be more sensitive to ACTH (Romeo et al., 2014). 
Therefore, age-related differences may be in part related to developmental shifts in 
adrenal structure and function. Nevertheless, pre-pubertal adolescents also release more 
ACTH in response to a stressor and have greater activation of the paraventricular nucleus 
(PVN) of the hypothalamus (Hodges & McCormick, 2015; Lui et al., 2012; Romeo et al., 
2006; Viau, Bingham, Davis, Lee, & Wong, 2005), which indicates developmental 
changes in the brain and possibly pituitary. Another possibility is that differences in HPA 
function are explained by age-related changes in gonadal status. In adult males, 
testosterone and the more potent androgen, dihydrotestosterone (DHT), have been shown 
to suppress the corticosterone response to stress and facilitate a return to baseline 
concentrations (Goel, Workman, Lee, Innala, & Viau, 2014; Handa & Weiser, 2014). 
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The suppressing effects of testosterone on circulating concentrations of 
corticosterone are likely unrelated to steroid clearance (Kitay, 1963a, 1963b) and, like 
age-related differences, can be observed at each level of the HPA axis (Green & 
McCormick, 2016; Romeo, 2013). There is more evidence for actions of androgens in the 
brain and pituitary, in part related to actions on androgen receptors (AR), which is 
supported by evidence that flutamide (an AR antagonist) increases stress responses in 
intact or androgen treated males (Gomez, Manalo, & Dallman, 2004; Lund, Hinds, & 
Handa, 2006). The neuroendocrine cells of the PVN are devoid of AR, however, which 
suggests that androgenic effects occur in upstream brain regions. The medial preoptic 
area (mPOA), which richly expresses AR and has connections to the PVN, is an 
important site for androgenic effects on HPA function. Direct administration of 
androgens to the mPOA reduced post-stress concentrations of corticosterone 
(McCormick, Linkroum, Sallinen, & Miller, 2002) and expression of Fos and AVP 
heteronuclear (hn)RNA in the PVN (Williamson, Bingham, Gray, Innala, & Viau, 2010), 
and lesions to this region prevented the dampening effects of testosterone (Viau & 
Meaney, 1996). 
In addition to actions at AR, androgen metabolites can directly affect PVN 
function and possibly upstream brain regions by acting on alternative receptor targets. It 
is well established that testosterone can be converted irreversibly to DHT via 5α-
reductase or to estradiol via aromatase (Handa & Weiser, 2014). Because DHT cannot be 
aromatized into estradiol, and because estradiol increases rather than suppresses HPA 
function via estrogen receptor α (ERα) (Lund et al., 2006; Lund, Munson, Haldy, & 
Handa, 2004), this pathway is not a likely candidate for the suppressing effects of 
80 
 
 
androgens. There is evidence, however, that DHT can be irreversibly converted to 3β-
diol, which can reduce HPA activation by binding to estrogen receptor β (ERβ) (Handa, 
Pak, Kudwa, Lund, & Hinds, 2008; Lund et al., 2006), a receptor that is expressed within 
a small population of neuroendocrine cells in the PVN, among other stress-related brain 
regions (Handa & Weiser, 2014).  
 Given that pre-pubertal adolescents have low levels of circulating androgens 
compared with that of adults, it seems likely that age-related differences in gonadal status 
account for the pronounced HPA responses seen before puberty. Contrary to this 
hypothesis, one study found that pre-pubertal adolescents continued to exert a more 
pronounced stress response than adults after both groups were OCXed (to eliminate 
testicular androgens) and given a comparable dose of testosterone (Romeo, Lee, Chhua, 
McPherson, & McEwen, 2004). These findings indicate that developmental shifts in HPA 
function are likely independent of differences in gonadal status. Therefore, in the present 
study, we attempted to replicate the finding that gonadal status is not the basis for age-
related differences in HPA function. Moreover, we investigated whether gonadal 
hormones can regulate HPA function before puberty, as the study by Romeo and 
colleagues (2004) examined age-related differences in the presence of testosterone, but 
did not examine testosterone’s effects at each age (i.e., no comparison with non-replaced 
males), which would provide a better indication of testosterone’s ability to dampen HPA 
function at each age. We included post-pubertal adolescent males (P45) that are still 
maturing and for which far less is known regarding HPA function, to better understand 
the transition into adulthood. To quantify HPA reactivity and recovery we measured 
plasma corticosterone concentrations as well as Fos (a marker of neuronal activation) and 
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AVP (a co-secretagogue of ACTH) expression in the PVN, all of which are dampened by 
androgen treatment in adulthood (Goel et al., 2014; Handa & Weiser, 2014). 
Experiment 1: Effects of GDX and testosterone replacement on HPA function 
before during and after puberty in male rats. 
Methods 
Animals 
Male Long-Evans rats were obtained at postnatal day (P) 24 (n = 48), P34 
(n = 32), and P64 (n = 32) (± 1 day) from Charles River (St. Constant, Quebec) in two 
batches, which were balanced for age. Animals were housed in same-aged pairs and 
acclimated to the colony for at least 4 days. Food and water was provided ad libitum and 
animals were kept on a 12 h light-dark cycle (lights on at 09:00). All procedures were 
approved by the Brock University Animal Care and Use Committee and were in keeping 
with the National Institute of Health Guide for Care and Use of Laboratory Animals 
(Publication No. 85-23, revised 1985) as well as the Canadian Council on Animal Care 
guidelines. 
Orchiectomy and testosterone treatment 
After the acclimation period, all males underwent an orchiectomy (OCX) surgery 
under isoflurane. Surgery occurred across 4 days, with 8 males from each age group 
receiving an OCX on each day (n = 32 per age). On days 3 and 4 of surgery, an additional 
8 males from the youngest age group underwent OCX (n = 48); we attempted to reduce 
the number of animals needed for the study by using repeated blood sampling (described 
below), but pilot experiments indicated that males at the younger age were too small to 
extract repeated samples from and thus, we included more males. After OCX, but while 
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still under isoflurane, half the males in each age group received a subcutaneous silastic 
tube implant that contained ~10 mg of testosterone. The other halves received a blank 
implant. 
Stress and sample collection 
 Four days after surgery, males from each age group were euthanized via rapid 
decapitation for the collection of brain tissue and trunk blood. Samples from those that 
underwent surgery on day 1 or 2, were collected directly from the home cage (baseline 
time-point) approximately 1 to 1.5 hours into the lights on phase of the light-dark cycle (n 
= 8 per age and hormone treatment) (see Fig. 3-1). The remaining males (those that had 
surgery on day 3 or 4), underwent 30 min of restraint stress in a Plexiglas® restrainer, 
which began 30 min into the lights-on phase. Because of the age-related differences in 
the size of the males, we utilized 3 different sizes of restrainer that permitted minimal 
mobility. Immediately after restraint stress (0 min post-stress time-point), the older age 
groups had blood samples taken from the tail vein within a minute, then were returned to 
their home-cage. Based on pilot data, we could not extract a sufficient amount blood from 
the tail vein of the younger group to perform hormone assays and thus, half of the 
animals from this age were euthanized via rapid decapitation for the collection of trunk 
blood. The remaining half of the younger cohort underwent the same tail snip and 
handling as the older groups, but was returned to the home-cage for the future collection 
of brains and trunk blood, which occurred 45 min after termination of the stress 
procedure (45 min post-stress time-point). This time-point was selected based on 
previous studies showing age-related differences in corticosterone and in Fos expression 
in the PVN between 0 and 45 min after 30 min of restraint stress (Lui et al., 2012; Romeo 
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et al., 2006). Additionally, these studies found that pre-pubertal adolescents reached peak 
expression as early as immediately after stress, whereas adults may take longer (Lui et 
al., 2012; Romeo et al., 2006). Therefore, we waited until 45 min after the end of restraint 
to be more confident that any age effect would not be related to differences in the speed 
at which the groups reached maximal expression. All blood samples were collected into 
ice-chilled tubes containing EDTA, spun for 10 min at 1,730 RCF and 4 ̊ C for the 
collection of plasma, which was kept at -20 ̊ C until hormones assays. Brains were 
rapidly extracted and sliced on ice along the coronal plane directly rostral and caudal to 
the hypothalamus and the sections were fixed via submersion in 4% paraformaldehyde 
containing 10%, then 20%, then 30% sucrose (~24 hours per concentration of sucrose). 
After fixation, brains were frozen for 1 hour at -20 ̊ C, then sliced into 40 µm coronal 
sections, with every fifth section pooled. Sections were stored in cryoprotectant at -20 ̊ C 
until immunohistochemistry experiments for the detection of Fos and AVP 
immunoreactive (ir) cells in the medial parvocellular PVN. 
Hormones assay 
 Steroids were extracted from plasma (25 μL for tail vein samples, 100 µL for 
trunk samples) using diethyl ether and the samples were reconstituted in buffer provided 
in the enzyme-linked immunosorbent assay kits for the detection of testosterone, 
corticosterone and progesterone (Neogen, Lansing, MI). Assay procedures were 
conducted as per kit instructions and sensitivity was 0.006, 0.05, and 0.4 ng/mL for 
testosterone, corticosterone, and progesterone, respectively. Concentrations of 
corticosterone were measured from samples collected at each of the 3 time-points to 
access stress reactivity and recovery. Testosterone concentrations were assayed in 
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baseline samples only and from those OCX males that received testosterone-replacement; 
pilot data indicated that concentrations were below the limit of detection in blank implant 
treated OCX males. For progesterone, baseline concentrations were assayed in males 
given a testosterone or blank implant. 
Immunohistochemistry 
Briefly, free-floating sections were washed thoroughly in 0.1 M PBS, then in 
PBS-X (0.1 M PBS with 3% Triton X-100), and incubated at room temperature in a 0.3% 
H2O2 in 0.1 M PBS-X solution for 30 mins. Sections were then washed in PBS-X, 
blocked at room temperature in 10% goat serum (Sigma) solution for 1 h, and incubated 
at 4 °C overnight in rabbit anti-AVP (1:30,000; Santa Cruz) or rabbit anti-Fos (1:20,000; 
Santa Cruz) in PBS-X. The next day, sections were washed in PBS-X and then incubated 
for 2 h at room temperature in a biotinylated goat anti-rabbit (1:4000; Vector 
Laboratories). After another series of washes in PBS-X, sections were incubated in an 
avidin–biotin horseradish peroxidase complex (Vector Laboratories) for 1.5 h at room 
temperature. Horseradish peroxidase was visualized with 3,3′-diaminobenzidine (DAB) 
in a 3 M sodium acetate buffer containing 0.05% H2O2 (Vector Laboratories). After a 
final series of washes in PBS-X, sections were mounted on Superfrost Plus slides (Fisher 
Scientific) and allowed to dry. Mounted sections were dehydrated using increasing 
concentrations of ethanol (70%, 95%, 100%, 3 mins each), then were placed in xylene 
(~3 mins), and coverslipped using Permount mounting medium (Fisher Scientific).  
Microscopy and cell counting 
Immunostained sections were imaged using a Nikon Eclipse 80i microscope 
equipped with a digital camera (Nikon DXM1200F) and Nikon ACT-1 software. Fos-ir 
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and AVP-ir cell counts were conducted at 400× magnification in a 250 µm2 area within 
each hemisphere of the medial parvocellular division of the paraventricular nucleus 
(PVN), where input from various stress-responsive brain regions is integrated to mount a 
hormonal stress response. Counts were made blind to experimental condition and the 
mean number of ir-cells were scored, which was taken by averaging counts from both 
hemispheres and across multiple sections (if present). 
Statistical analyses 
 Analyses involved 1-way (for testosterone; age), 2 factor (for progesterone; age, 
treatment) and 3 factor (for corticosterone, Fos, and AVP; age, treatment, time-point) 
ANOVAs. Alpha was set at p < 0.05 and post hoc tests were Bonferroni-corrected.  
Results 
Hormones  
 Testosterone concentrations were ~2 ng/mL in OCX males given testosterone 
implants, and did not differ by age (F2,21 = 0.2, p = 0.825; see Fig. 3-2A). This 
concentration corresponds to approximately low-to-mid physiological concentrations of 
testosterone (Viau & Meaney, 1996) and is similar to those in sham-operated, adult males 
(Seale, Wood, Atkinson, Harbuz, & Lightman, 2004). 
Baseline concentrations of progesterone differed by age (F2,42 = 5.5, p = 0.007; 
see Fig. 3-2B); P35 males had greater concentrations than did P45 males (p = 0.006), and 
P75 did not differ from either age group (ps = 0.476 and 0.203, respectively). The effect 
of age did not depend on treatment condition (F2,42 = 0.1, p = 0.865). Testosterone 
replacement increased baseline concentrations of progesterone, but the effect was not 
statistically significant (F1,42 = 3.2, p = 0.081). 
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There was a significant interaction of age, treatment, and time-point on 
concentrations of corticosterone (F4,119 = 5.6, p < 0.001). Follow-up analyses were split 
by time-point, which indicated no effect or interaction of age and treatment at baseline or 
at 45 min post-stress (all ps > 0.1) (see Fig. 3-2C, left and right panels). At the recovery 
time-point, concentrations approached baseline (<5 μg/dL) in all groups. Based on 
previous research (Romeo et al., 2004), we predicted that the effect of testosterone on 
corticosterone concentrations immediately after stress would depend on age. Consistent 
with our predictions we found a significant interaction of the 2 factors (F2,38 = 5.3, p = 
0.009). Therefore, we conducted follow-up analyses split by treatment and by age to 
examine developmental changes in HPA function and its modulation by testosterone.  
Testosterone replacement had no effect on post-stress concentrations of 
corticosterone at P35 (p = 0.690) or at P75 (p = 0.150), but increased concentrations at 
P45 compared with those that received blank implants (t13 = 3.0, p = 0.010) (see Fig. 3-
2C, middle panel). The lack of a difference at P75 was unexpected considering that 
testosterone typically dampens stress reactivity in adulthood (Goel et al., 2014; Handa & 
Weiser, 2014); our data, however, are in the same direction and involved small groups (6-
7 per treatment at P75). When we split by treatment, we found evidence of developmental 
shifts in HPA function; among OCX males given a blank implant, P35 males had higher 
concentrations than did P45 (p = 0.003) and P75 males (p = 0.033), but there was no 
difference between P45 and P75 males (p = 1.0). In contrast, among OCX males given a 
testosterone implant, P35 and P45 males had higher concentrations compared with P75 
(ps = 0.001 and 0.004, respectively), but did not differ from one another (p = 1.0). 
Expression of Fos and AVP in the PVN 
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 There was an effect of time-point (post-stress > stress; F1,69 = 21.9, p < 0.001), a 
near effect of age (F2,69 = 2.9, p = 0.064), and no effect of treatment (F1,69 = 1.1, p = 
0.290), on the number of Fos-ir cells in the PVN (see Fig. 3-3B and 3-3D). These effects, 
however, were obviated by a significant 3-way interaction (F2,69 = 4.9, p = 0.010). 
Follow-up analyses split by time-point revealed a significant 2-way interaction at 
baseline (F2,37 = 5.5, p = 0.008) and no effect or interaction of age and treatment 45 min 
post-stress (ps > 0.1). The difference at baseline was because of greater expression of 
Fos-ir in testosterone treated P35 males compared with P45 and P75 males that had the 
same treatment (ps = 0.036 and 0.018, respectively). These difference, however, were 
largely driven by heightened ir-cell counts in the PVN in two P35 rats (cage partners) and 
may not be indicative of typical baseline expression.  
 There was a main effect of treatment on the number of cells expressing AVP-ir in 
the PVN (F1,72 = 8.6, p = 0.004) with fewer ir-cells in testosterone treated males 
compared with those with a blank implant, irrespective of age and of time-point (see Fig. 
3-3C and 3-3E). There were no main effects or interactions involving age (ps > 0.1) or 
time-point, although there was a trend for more cells to express AVP 45 min after stress 
compared with baseline (F1,72 = 3.0, p = 0.088). 
Discussion 
Consistent with a previous finding (Romeo et al., 2004), we found that the 
magnitude of the stress response was greater in pre-pubertal adolescent (P35) males 
compared with adult (P75) males, and the difference is not related to gonadal status. 
When we administered an equivalent dose of testosterone to males of both age groups, 
pre-pubertal males continued to have greater circulating concentrations of corticosterone 
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after restraint stress. We also extended the previous research by demonstrating that 
testosterone administration to pre-pubertal adolescent males is not capable of dampening 
the corticosterone response to stress, as it typically does in adulthood (Handa & Weiser, 
2014). This does not mean that this age group is unresponsive to testosterone, because we 
found that testosterone reduced AVP-ir cell counts in the PVN of males at all ages 
examined. Thus, testosterone can modulate HPA function before puberty, but this is 
likely region-dependent and produces no effect on corticosterone output. 
We included post-pubertal adolescent (P45) males for which there are fewer 
investigations of HPA function and found that their responses differed from their younger 
and older comparisons. Post-pubertal adolescent males treated with testosterone had 
greater post-stress concentrations of corticosterone than did adults, but did not differ from 
pre-pubertal adolescents. In contrast, post-pubertal adolescents without testosterone 
replacement responded like adults and had lower concentrations than pre-pubertal 
adolescents. Therefore, there are developmental shifts in HPA function that occur in the 
time around puberty and that depend on both the presence and absence of testosterone. 
That testosterone increased the corticosterone response to restraint stress at this age is 
contrary to the dampening effect of testosterone that is typically found in adulthood (Goel 
et al., 2014; Handa & Weiser, 2014). In the present study, the dampening effect of 
testosterone in adults was not significant, although the difference was in the right 
direction. The difference may have been significant had adult males received a larger 
dose; adults had plasma concentrations of ~2 ng/mL, which could be considered a low 
physiological dose compared to what is typically seen in intact adult males (~4 ng/mL; 
see Chapter 2, Fig.  2-1A). Individual differences in testosterone in circulation are 
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associated with the extent of the dampening effect on stress-induced corticosterone 
release and PVN activation (McCormick & Mahoney, 1999; Viau, Lee, Sampson, & Wu, 
2003; Viau & Meaney, 1996). 
The basis for the higher corticosterone concentrations in testosterone-treated 
versus non-treated OCX males at P45 may involve a higher conversion of testosterone to 
estradiol at this age. A previous study found that, compared with young adults (P68), pre-
pubertal juveniles (P28) and post-pubertal adolescents (P48) had more than twice the 
amount of aromatase activity in the hypothalamus (Lephart & Ojeda, 1990). Moreover, 
aromatase activity was up-regulated by androgens acting on AR in stress-related brain 
regions (e.g., bed nucleus of the stria terminalis and mPOA) (Roselli & Resko, 1993), 
and the androgen-induced increase was greater in pre-pubertal and post-pubertal 
adolescent males compared with adult males (Lephart & Ojeda, 1990). Greater aromatase 
activity in the hypothalamus (and possibly other regions) may be critical for sexual 
differentiation of the brain during adolescence; in early-life, conversion of testosterone to 
estradiol via aromatase masculinizes the hypothalamus and adult reproductive behaviour 
and HPA function (Bingham, Gray, Sun, & Viau, 2011; Bingham, Wang, Innala, & Viau, 
2012; McCarthy & Konkle, 2005). The mPOA richly expresses aromatase (Tabatadze, 
Sato, & Woolley, 2014) and undergoes sexual differentiation during adolescence (Ahmed 
et al., 2008; McCarthy & Konkle, 2005), indicating that it is a target for estrogenic 
actions at this age. Therefore, pronounced conversion of testosterone to estradiol may 
account for the increased stress response at P45. Furthermore, androgen regulation of 
aromatase in pre-pubertal adolescent males provides further evidence that this age group 
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can respond to androgens in stress-related brain regions, as we saw with AVP expression, 
despite corticosterone concentrations being unaffected.  
Previous studies have found that removal of testicular androgens via OCX 
increases post-stress expression of AVP heteronuclear (hn) and messenger (m) RNA in 
the PVN (Seale, Wood, Atkinson, Bate, et al., 2004; Viau et al., 2003), and that 
peripheral administration of testosterone dampened its expression (Evuarherhe et al., 
2009; Seale, Wood, Atkinson, Harbuz, et al., 2004). Moreover, post-stress expression of 
AVP mRNA in the PVN and resting-state AVP protein in the median eminence (where it 
is secreted to affect pituitary release of ACTH) were negatively correlated with 
circulating concentrations of testosterone (Viau et al., 2003; Viau & Meaney, 1996), 
which indicates that the dampening effect of testosterone on AVP expression is not all-
or-none, but depends on the amount in circulation. DHT also reduced post-stress 
expression of AVP hnRNA in the PVN, but did not affect baseline expression (Lund et 
al., 2004). Not all findings are consistent; others found no effect of androgen treatment on 
AVP (Bingaman, Magnuson, Gray, & Handa, 1994; Viau, Chu, Soriano, & Dallman, 
1999). Nevertheless, our findings are consistent with the bulk of evidence showing a 
dampening effect of testosterone on AVP expression in the PVN, which was present at 
baseline and after 45 minutes of recovery from stress. Additionally, we provide novel 
evidence that the suppressing effect of testosterone on AVP expression is present in pre-
pubertal and post-pubertal adolescents, which suggests AVP is not the basis for age-
related differences in the corticosterone response to stress. 
As expected, stress increased the expression of Fos in the PVN, as measured 45 
minutes after restraint stress compared with males taken directly from the home-cage. 
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Although we did not observe a significant effect of age (p = 0.064), our data was in the 
same direction as past studies that found pre-pubertal adolescents had more Fos 
expression in the PVN compared with adults (Lui et al., 2012; Romeo et al., 2006; Viau 
et al., 2005). Additionally, we did not observe a dampening effect of testosterone, which 
we expected based on previous findings in adults showing that OCX increased its 
expression after stress and that post-stress Fos expression was negatively correlated with 
testosterone in intact males (Viau et al., 2003). In adult males, the dampening effect of 
testosterone seems to involve actions on AR in the mPOA; direct implants of testosterone 
reduced expression of c-fos mRNA and Fos protein in the PVN, and this effect was 
reversed with hydroxyflutamide (an AR antagonist) (Williamson et al., 2010). Moreover, 
lesions to the mPOA block the inhibitory effect of testosterone on PVN Fos expression 
(Williamson & Viau, 2008). DHT treatment also reduced post-stress expression of c-fos 
mRNA in the PVN of OCX males, whether it was administered peripherally (Lund et al., 
2004) or directly above the PVN (Lund et al., 2006). The lack of an effect of testosterone 
or of age in the present study may be related to the fact that, like corticosterone, the two 
factors tended to interact on post-stress expression of Fos in the PVN. Unlike 
corticosterone concentrations, however, there was considerable variability in Fos 
expression within each group, which may have obfuscated effects.  
Taken together, the results of experiment 1 indicate that developmental changes in 
gonadal status (i.e., testosterone concentrations) do not explain age-related differences in 
HPA function. Additionally, testosterone’s regulation of HPA function changes across 
the adolescent period and into adulthood, as evidenced by differential effects on the 
release of corticosterone. Nevertheless, males at each age were responsive to testosterone 
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in a region- and marker-dependent manner, which leads us to hypothesize that 
testosterone is being differentially converted to various metabolites at each age. 
Therefore, in a second experiment, we tested this hypothesis to explain age-related 
differences in testosterone’s regulation of the corticosterone response to stress.  
Experiment 2: Antagonism of receptor targets of androgens and effects of HPA 
stress responses in pre-pubertal and post-pubertal adolescent and adult male rats. 
 In experiment 2, we sought to replicate the age-specific effects of testosterone on 
the corticosterone response to stress found in experiment 1. Further, we included DHT- 
treated males, because unlike testosterone, DHT cannot be converted to estradiol. We 
also utilized AR and ER antagonists to identify the receptor targets of androgens at each 
age to explain the findings from experiment 1. We tested the hypothesis that the higher 
stress-induced corticosterone release in testosterone-treated P45 males involves actions at 
ER receptors, if testosterone is undergoing greater conversion to estradiol to act on ERα. 
Because DHT has been shown to suppress HPA responses through actions on AR or via 
conversion to 3β-diol and actions on ERβ in adults (Handa, Sharma, & Uht, 2011), 
application of AR or ER antagonists should attenuate the effect of DHT. We had no 
predictions for ER and AR antagonism in pre-pubertal adolescents. 
Methods 
Animals 
Male Long Evans rats arrived at P23, P33, or P63 (n = 56 per age group) from 
Charles River (St. Constant, Quebec) in four batches, which were balanced across ages. 
Animals were housed in same age, same condition (described below) pairs, given free 
access to food and water, and kept on a 12 hour light-dark cycle (lights on at 10:00). All 
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procedures were approved by the Brock University Animal Care and Use Committee and 
were in keeping with the National Institute of Health Guide for Care and Use of 
Laboratory Animals (Publication No. 85-23, revised 1985) as well as the Canadian 
Council on Animal Care guidelines.  
Orchiectomy, hormone replacement, and receptor antagonism 
After 5 days of acclimation to the colony, all males underwent an orchiectomy 
(OCX) and received a silastic tube implant (S.C.; 1.57 mm i.d., 3.18 mm o.d.; Dow 
Corning) that contained testosterone (2 cm length; ~10 mg) or DHT (1 cm length; ~5 
mg), while under isoflurane. One day after surgery, males were given daily injections of 
sesame oil (vehicle group) or flutamide (25 mg/kg) or tamoxifen (1 mg/kg) suspended in 
sesame oil for 6 days. This dose of flutamide was sufficient to suppress pubertal 
maturation of the gonads and elevated testosterone concentrations in intact male rats 
(Shin et al., 2002). The dose and injection regimen of tamoxifen is the same as that used 
by Lund and colleagues. (2006), which was sufficient to block gonadal hormonal 
modulation of HPA function in adult males. We also included OCX males given a blank 
(empty) implant and vehicle injections, which provided a comparison group for those 
with hormone replacement. Therefore, for each of the 3 ages, there were 7 different 
conditions with 8 males per group and, because experiments were run in 4 batches, we 
included 2 males from every age and condition in a batch. Two adult males from the 
DHT-tamoxifen group were removed from the experiment because they had developed 
an infection. 
Stress and sample collection 
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 On P35, P45, or P75, male rats from each condition underwent 30 min of restraint 
stress, which began ~ 1 to 3.5 hours into the light-dark cycle. The order of testing was 
counter balanced across ages and conditions and different size restrainers were used for 
each age group, which provided limited mobility for all rats. Immediately after restraint, 
males were rapidly decapitated for the collection of trunk blood into ice-chilled glass 
tubes containing EDTA and were centrifuged at 3000 RCF for 10 min for the collection 
of plasma, which was frozen at – 20 ̊ C until we performed steroid extraction and 
hormone assays. 
Hormone assays 
 Steroids were extracted from plasma (100 µL) using diethyl ether and the samples 
were reconstituted in buffer provided in the enzyme-linked immunosorbent assay kits for 
the detection of corticosterone and progesterone (Neogen, Lansing, MI). Assay 
procedures were conducted as per kit instructions and using a Biotech Synergy plate 
reader. All samples were run on the same day and sensitivity was 0.05 and 0.4 ng / mL 
for corticosterone, and progesterone, respectively.  
Statistical analyses 
 Because we found no effect of tamoxifen on any measures, we cannot be certain 
that our manipulation was effective and thus, we excluded the tamoxifen groups from 
subsequent analyses. Exclusion of the tamoxifen groups did not change the results and 
simplified the presentation of the data. We used 2 factor (treatment, age) ANOVAs to 
compare OCX males that received empty implants (and vehicle) to those given 
testosterone (or DHT) along with vehicle or flutamide. Alpha was set at p < 0.05 and post 
hoc tests were Bonferroni-corrected.  
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Results 
Corticosterone 
 We compared OCX males without replacement to those given testosterone and 
vehicle or testosterone and flutamide. There was no effect of treatment (F2,62 = 1.3, p = 
0.279), no effect of age (F2,62 = 1.6, p = 0.213), nor an interaction of the two factors (F4,62 
= 0.9, p = 0.462). Nevertheless, visual examination of the data (see Fig. 3-3A) reveals 
that age-specific effects of testosterone were in the same direction as experiment 1 results 
(see Fig. 3-1A).  
When we compared OCX males to those given DHT and vehicle or flutamide, we 
found no effect of condition (F2,62 = 0.8, p = 0.453) or of age (F2,62 = 1.4, p = 0.257), nor 
an interaction of the two factors (F4,62 = 0.2, p = 0.930). 
Progesterone 
When we compared OCX males to those given testosterone and vehicle or 
flutamide on post-stress concentrations of progesterone, we found no effect of age (F2,62 
= 1.4, p = 0.246), and an effect of condition (F2,62 = 4.5, p = 0.014) that did not depend on 
age (F4,62 = 0.8, p = 0.510). OCX males without hormone replacement did not differ from 
those given testosterone and vehicle (p = 0.110) or testosterone and flutamide (p = 1.0). 
Among those given testosterone, flutamide increased the progesterone response to stress 
relative to vehicle treatment (p = 0.013).  
When we compared OCX males without hormone replacement to those that given 
DHT and vehicle or flutamide, we found an effect of condition (F2,62 = 5.2, p = 0.008), 
but not of age (F2,62 = 1.6, p = 0.202), and no interaction of the two factors (F4,62 = 1.6, p 
= 0.187). DHT reduced progesterone relative to those without hormone replacement (p = 
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0.016) and flutamide fully reversed the effect of DHT (p = 0.028). Those without 
replacement did not differ from those that got DHT and flutamide (p = 1.0). 
General Discussion 
 In experiment 1, we found that age-related differences in the corticosterone 
response to stress were not explained by changes in gonadal status; when pre-pubertal 
adolescent males were given testosterone, they continued to respond more strongly than 
did adults (see Fig. 3-1C, middle panel). Moreover, we found that testosterone had no 
effect on post-stress concentrations of corticosterone in pre-pubertal adolescents, 
increased concentrations in peri-pubertal adolescents, and moderately reduced 
concentrations in adults compared with non-replaced OCX males. In experiment 2, we 
sought to replicate this finding and found evidence for the same pattern of results, 
although this time the differences failed to reach statistical significance (see Fig. 3-3A).  
A potential source of variation in experiment 2 may be related to the repeated 
daily injections (6x) that males received prior to stress exposure. To examine the receptor 
targets of androgens, rats were repeatedly injected with AR or ER antagonists and 
measured post-stress corticosterone and progesterone concentrations. This protocol was 
like that used by Lund, Hinds, and Handa (2006), who characterized the contribution of 
various receptor targets on modulating HPA function in adult males. In the present study, 
however, it may be that repeated handling and injections added additional stressors, and 
thus the corticosterone results reflect the history of chronic stress rather than acute stress.  
Prior stress history is known to influence HPA responses to stress. In response to 
a homotypic stressor (i.e., a stressor that has been repeatedly experienced in the past), 
adults will release less ACTH and corticosterone compared with those that experience the 
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stressor for the first time, providing evidence of habituation (Lui et al., 2011; Romeo, 
2010). In contrast, when confronted with a heterotypic stressor (a new stressor), adults 
often respond more strongly than those that experience the same stressor for the first time 
(Grissom & Bhatnagar, 2009).  
Age-related differences exist, however, regarding how stress history affects HPA 
responses. Pre-pubertal adolescents do not habituate and may become sensitized to a 
homotypic stressor, responding as strongly or stronger than those who undergo the 
stressor for the first time {Romeo et al., 2006; Lui et al., 2011). Importantly, activation of 
the PVN is suppressed in response to a homotypic stressor at both ages, although the age-
related difference still remains (Lui et al., 2011), which suggests that adolescent 
sensitization may relate to changes in the pituitary and/or adrenals. In response to 
heterotypic stressors, the age-related difference in corticosterone release was partially 
mitigated (Lui et al., 2012), which may explain why we failed to see a significant effect 
of age in experiment 2. Less is known about how gonadal hormones modulate responses 
to homotypic and heterotypic stressors, but the present results suggest that the effects of 
androgens on HPA responses are mitigated when the stressor is heterotypic in nature. 
We predicted that tamoxifen would reduce the corticosterone response to stress in 
P45 males given testosterone, because we hypothesized that the pronounced stress 
response seen in experiment 1 was related to greater conversion of testosterone to 
estradiol. We found no effect of tamoxifen at any age, however, which led us to drop 
these groups from the analyses. This finding is in contrast with previous studies that 
showed that tamoxifen partially blocked the dampening effect of DHT on HPA measures 
after stress in adulthood (Lund et al., 2006). In the present study, we also failed to see a 
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dampening effect of DHT on corticosterone, which has been previously demonstrated 
following central or peripheral administration in adult rats and mice (Handa, Kudwa, 
Donner, McGivern, & Brown, 2013; Lund, Munson, Haldy, & Handa, 2004a, 2004b). 
This led us to believe that the dose of DHT that we administered was not sufficient to 
reduce HPA function, but when we examined progesterone, DHT significantly reduced 
concentrations in males of all ages. Therefore, either DHT can regulate progesterone, but 
not corticosterone at the dose given, or this may be further evidence that repeated 
injection stress masked the effects of gonadal hormones on the corticosterone response to 
stress.  
The same effect was observed with testosterone treatment, whereby progesterone 
concentrations were reduced compared with no testosterone treatment groups (p = 0.1), 
particularly at P45 and P75, but corticosterone concentrations remained less affected. In 
both DHT- and testosterone-treated males, flutamide increased post-stress concentrations 
of progesterone, which indicates androgen-induced suppression of progesterone involves 
actions at AR. The dampening effect of androgens on progesterone release conflicts with 
a previous report that corticosterone release in response to acute stress is reduced after 
OCX in pre-pubertal and adult males (Kalil, Leite, Carvalho-Lima, & Anselmo-Franci, 
2013; Romeo, Bellani, & McEwen, 2005). Our results showing that androgens decreased 
progesterone but not corticosterone after exposure to a heterotypic stressor point to the 
adrenals as a target for androgenic effects, possibly by altering the expression of enzymes 
involved in steroidogenesis. We (in Chapter 2) and others (Hueston & Deak, 2014) have 
previously shown that release of the two hormones in response to stress are highly 
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correlated, but there may be bias away from corticosterone synthesis after repeated 
exposure to stressors that renders differences in progesterone more prominent.  
As mentioned, a potential limitation of the present study is the repeated injection 
stress that males underwent before measuring their hormonal responses to restraint. 
Moreover, there may have been an effect of shipment or OCX surgery that interacted 
with age, which further compounded the stress history of the animals. Future studies 
should minimize the stress history of the animals by comparing the effects of age and 
treatment in those born within the colony and following fewer, less stressful 
manipulations, possibly by administering antagonists via implants rather than repeated 
injection. It would also be advantageous to examine other markers of HPA function to 
determine the sites of androgenic effects in males of different ages. We suspect that age-
related differences in gonadal regulation of HPA function may involve actions in 
peripheral and central regions where aromatase and 5α-reductase are expressed. 
Taken together, we have shown that developmental changes in gonadal status 
does not account for age-related differences in HPA function. Moreover, we have 
provided evidence of changes in gonadal regulation of HPA function throughout the 
adolescent period and into adulthood, which were region specific and may involve 
differential steroid metabolism in the brain and periphery. Findings from the present 
study and from past research indicate that androgens can regulate certain HPA markers 
(AVP) and enzymatic activity before puberty (Lephart & Ojeda, 1990), indicating that 
this age group is sensitive gonadal hormones. More research is required to tease apart the 
mechanisms that mediate changes in gonadal regulation of HPA markers during this 
period.  
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Figures 
 
Figure 3-1. Experimental time-table for experiment 1. Male rats of different ages were 
OCXed and administered an implant that contained testosterone or was left blank on one 
of four days. Four days after surgery, rats were tested, which involved the collection of 
blood and brains either directly from the home-cage (Baseline groups) or after exposure 
to restraint stress (Restraint groups). 
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Figure 3-2. Mean (± S.E.M.) concentrations of testosterone (A), progesterone (B), and 
corticosterone (C). (A) baseline concentrations of testosterone in OCX males of various 
ages (P35, P45, P75) that received a testosterone implant. (B) baseline concentrations of 
progesterone in OCX males of different ages that received a blank implant (light grey) or 
a testosterone implant (dark grey). (C) concentrations of corticosterone at baseline (left 
panel), 0 min post-stress (middle panel), and 45 mins post-stress (right panel) in OCX 
males of different ages that received a blank implant (light grey) or a testosterone implant 
(dark grey). Different lower-case letters indicate an age-related difference in 
corticosterone among those that received a blank implant. Different upper-case letters 
indicate an age-related difference in corticosterone among those that received a 
testosterone implant. ^ indicates a significant effect of treatment (blank vs testosterone) 
within an age group. 
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Figure 3-3. Representative images of the medial parvocellular PVN (A) stained for Fos 
(B) or for AVP (C). Mean  (± S.E.M.) number of cells expressing Fos-ir in the PVN (D) 
in OCX males of different ages (P35, P45, P75) at baseline (light grey) or 45 mins after 
restraint stress (dark grey). * indicates a significant effect of time-point. Mean (± S.E.M.) 
number of cells expressing AVP-ir in the PVN (E) in OCX males of different ages that 
received a blank implant (light grey) or a testosterone implant (dark grey) * indicated a 
significant effect of testosterone treatment. 
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Figure 3-4. Experimental timetable for experiment 2. Male rats at different ages were 
OCXed and given an implant of testosterone or DHT or one that was left empty. The day 
after surgery, males were given 6 daily injections of vehicle, tamoxifen, or flutamide, and 
the next day blood samples were collected immediately after 30 minutes of restraint 
stress. 
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Figure 3-5. Mean (± S.E.M.) concentrations of corticosterone immediately after restraint 
stress in males of different ages (P35, P45, P75) that received a blank implant versus 
those that got a testosterone implant (A) or a DHT implant (B) along with injections of 
vehicle or flutamide. Mean (± S.E.M.) concentrations of progesterone immediately after 
restraint stress in males that received a blank implant versus those that got a testosterone 
implant (C) or a DHT implant (D) along with injections of vehicle or flutamide.  
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Rationale for Chapter 4 
In the previous chapters, I demonstrated marked shifts in neuroendocrine response 
to stress across the adolescent period and showed that age-related differences are not 
likely related to GR mediated feedback in the hippocampus or to differences in GR co-
chaperones. Moreover, I provided evidence that age-related differences are not mediated 
by gonadal status and that gonadal hormones influence HPA responses differently before, 
during, and after puberty. These experiments involved male rats only, and it is important 
to understand how ovarian hormones regulate HPA function at different ages. As a first 
step towards such a goal, in this chapter, I investigated gonadal regulation of HPA 
responses in adult female rats. Previous studies have revealed that estradiol increases 
stress reactivity and delays the return of corticosterone to baseline (Green & McCormick, 
2016), but the findings are not always consistent and variability has been attributed to the 
duration and dosage of estradiol replacement. Therefore, I used a combination of 
treatment regimens to examine the effects of ovarian hormones on stressor-induced 
hormonal responses (corticosterone and progesterone) and to investigate potential 
mechanisms underlying their effects. Evidence that estradiol slows stress recovery and 
produces an anti-translocation profile of mRNA expression of GR co-chaperones, in 
vitro, led me to investigate similar measures that were included in chapter 2. Specifically, 
we measured GR translocation in response to acute stress and mRNA expression of co-
chaperones and co-activators, which can modulate GR’s transcriptional activity, in the 
hippocampus. The hippocampus was selected based on its role in HPA negative 
feedback.  
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Chapter 4: The effects of ovarian hormones on stressor-induced hormonal 
responses, glucocorticoid receptor expression and translocation, and genes related 
to receptor signaling in adult female rats. 
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Introduction 
  The hypothalamic-pituitary-adrenal (HPA) axis regulates the release of 
glucocorticoids (primarily corticosterone in rats). In response to a stressor, increased 
HPA signaling leads to greater release of glucocorticoids, which act throughout the body 
on glucocorticoid and mineralocorticoid receptors (GR and MR, respectively). Increased 
binding of glucocorticoids at receptor targets alters energy metabolism, immune function, 
and cognitive processes to cope with the stressor (Sapolsky et al., 2000). Moreover, 
increased GR binding at each level of the axis and in upstream brain regions (e.g., 
hippocampus and prefrontal cortex) results in negative feedback, whereby HPA activity 
is suppressed, facilitating a return to baseline concentrations of glucocorticoids (Herman 
et al., 2012). Whereas brief and infrequent exposures to glucocorticoids can be adaptive 
for coping with stressors, too much exposure is associated with ‘wear and tear’ on the 
body (e.g., cardiovascular disease and immune dysfunction) and an increased risk for 
psychopathologies such as depression (Juster et al., 2010; McCormick & Green, 2013).  
 In adult rodents, females have higher baseline and stressor-induced concentrations 
of corticosterone in circulation compared with males (Babb et al., 2013; Iwasaki-Sekino 
et al., 2009; Kitay, 1961; Seale et al., 2004a; Viau et al., 2005). Furthermore, after a 
stressor, females take longer to return to baseline concentrations than do males, which 
suggests that females have reduced HPA feedback (Iwasaki-Sekino et al., 2009; Kitay, 
1961; Weinstock et al., 1998). These sex differences are attributed foremost to circulating 
concentrations of gonadal hormones; after ovariectomy, females tend to respond like 
gonadally-intact males, and estradiol replacement potentiates HPA activity and reduces 
negative feedback (Burgess & Handa, 1992; Kalil et al., 2013; Kitay, 1963; Lunga & 
Herbert, 2004; McCormick et al., 2002; Seale et al., 2004b; Viau & Meaney, 1991; 
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Weiser & Handa, 2009; Young, 1996). The stimulatory effects of estradiol are also 
observed in cycling females, which have more pronounced and prolonged stress 
responses during proestrus when concentrations of circulating estradiol are highest, 
compared with other phases of the cycle (Atkinson & Waddell, 1997; Carey et al., 1995; 
Viau & Meaney, 1991). Estradiol may reduce negative feedback by altering the 
expression of corticosteroid receptors. For example, estradiol decreased the expression of 
GR mRNA in the hypothalamus and hippocampus of ovariectomized rats (Burgess & 
Handa, 1993; Peiffer et al., 1991; Seale et al., 2004b). Moreover, ovariectomy increased 
the number of cytosolic binding sites for dexamethasone in the hippocampus, 
hypothalamus, and pituitary of adrenalectomized rats (Turner, 1990; Turner & Weaver, 
1985). Other studies, however, found no effect of estradiol on binding in stress-related 
brain regions (Burgess & Handa, 1992; Ferrini et al., 1990). 
 The dampening effects of estradiol on HPA feedback may extend beyond the 
number of available corticosteroid receptors to factors that modulate their assembly and 
activity. In support of this hypothesis, administration of a GR agonist reduced GR mRNA 
expression in the hippocampus of ovariectomized rats, but not in females given estradiol 
replacement, indicating that estradiol interferes with GR autoregulation (Burgess & 
Handa, 1992, 1993). A mechanism by which estradiol may alter GR signaling is by 
reducing GR’s transcriptional activity via dephosphorylation (Zhang et al., 2009) or 
changing the expression of enhancers/repressors (e.g., SRC-1) (Mitev et al., 2003). There 
is also evidence that ovarian hormones affect the localization of GR; ovariectomized rats 
had more nuclear GR in the hippocampus than did sham controls when tested at baseline 
(Sheng et al., 2003). Another study found that estradiol produced an anti-translocation 
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profile in hippocampal cell culture; mRNA expression of Fkbp5 and Ppid were up- and 
down- regulated by estradiol, respectively (Malviya et al., 2013). Fkbp5 codes for the 
FK506-binding protein 51 (Fkbp51), which reduces both GR’s affinity for its ligands and 
its ability to translocate to the nucleus, whereas Ppid protein promotes translocation 
(Binder, 2009; Ratajczak et al., 2009; Wochnik et al., 2005). Nevertheless, no studies 
have examined the effects of ovariectomy or of ovarian hormone replacement on GR 
localization changes in response to an acute stressor, nor has their effects on co-
chaperones been investigated in vivo. 
 To characterize the actions of estradiol on HPA function and GR signaling, we 
investigated its effects on plasma corticosterone, GR translocation and the expression of 
genes that code for corticosteroid receptors, co-chaperones, and a co-activator. We 
administered estradiol alone or in combination with progesterone to ovariectomized 
females and measured protein and mRNA expression in the hippocampus because of its 
involvement in negative feedback (Herman et al., 2012). Progesterone treatment was 
included because it was found to mitigate the effects of estradiol on HPA activity and 
feedback (Viau & Meaney, 1991) and can affect corticosteroid receptor binding (Carey et 
al., 1995). We hypothesized that estradiol, alone or in combination with progesterone, 
would increase baseline and post-stress corticosterone, consistent with past studies, and 
reduce expression of cytosolic GR in the hippocampus as well as stressor-induced GR 
translocation. Further, we hypothesized that baseline mRNA expression of corticosteroid 
receptor would be concomitantly reduced, whereas genes coding for anti-translocation 
(e.g., Fkbp5 and Bag1) and pro-translocation (Fkbp4) co-chaperones may be augmented 
and dampened by estradiol treatment, respectively. 
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Methods 
Experiment 1: Effects of ovarian hormones on HPA responses and GR translocation 
 Animals 
 Adult female Long-Evans rats (N = 100) were obtained from Charles River at 
approximately postnatal day 60 (P60), housed in same treatment pairs (described below), 
and were acclimated to the colony for one week. Rats remained gonadally-intact (non-
ovariectomized [OVX], n = 20) or were bilaterally OVX by the supplier (n = 80). All rats 
were maintained on a 12-hour light-dark cycle (lights on at 0900) with food and water 
available ad libitum. Procedures were in keeping with the National Institutes of Health 
Guide for Care and Use of Laboratory Animals (Publication No. 85-23, revised 1996) 
and the Canadian Council on Animal Care guidelines, and were approved by the Brock 
University Animal Care and Use Committee. 
Experimental manipulations and sample collection 
Although all females were obtained at the same time, they were tested in batches 
and were 1-2 months post-OVX at the time. Females were assigned randomly to one of 
five treatments (n = 20 per treatment). OVX females received four days of daily 
subcutaneous injections of vehicle (VEH), estradiol benzoate (EB, 25 µg/kg in ~250 µl of 
sesame oil vehicle, dosing regimen based on [Weiser & Handa, 2009]), or EB and 
progesterone (EB+P) (P: 0.5 mg in 200 µl of sesame oil vehicle, based on [McCormick & 
Singh, 1996]), and one group received vehicle on days 1 and 3, EB on day 2, and P on 
day 4 (EB+P [FD]; fewer doses), which was done to better match the hormonal profile of 
naturally cycling female. The EB+P(FD) treatment regimen is comparable to that used to 
produce behavioral estrus in OVX rats (McCormick et al., 2013). The non-OVX females 
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received a daily vehicle injection to control for any effects of handling and injection 
stress. Injections before the test day were given during the lights on phase (between 1100 
and 1700) and, on the day of testing, injections and sample collection occurred from 
0800-0900 and from 1100-1200, respectively (restraint stress started as early as 10:30).  
Trunk blood and brain tissue was collected via rapid decapitation without 
anesthetic either directly from the home cage (baseline) or after 30 minutes of restraint 
(post-stress) in Plexiglas® restrainers (n = 10 per group). Blood samples were collected 
in ice-chilled glass tubes containing EDTA and were centrifuged at 4˚C (3000 RCF for 
15 min) for the collection of plasma, which was kept at -20˚C until assayed. Brains were 
extracted rapidly, sliced into 1 mm thick coronal sections, and placed onto ice-chilled 
slides, which were immediately frozen on dry-ice. Brain sections were stored at -80˚C 
until tissue processing. 
Hormone assay 
 Corticosterone and progesterone steroids were extracted from baseline and post-
stress plasma samples using diethyl ether and reconstituted in buffer provided in the 
enzyme-linked immunosorbent assay kits (Neogen, Lansing MI), which were run 
according to the kit instructions and quantified using a Biotech Synergy plate reader. 
Assay sensitivity was 0.05 ng/mL for corticosterone and 0.4 ng/mL for progesterone. 
Intra- and inter-assay variabilities were < 5% and 12%, respectively for both hormones. 
Protein extraction 
To determine GR expression in the cytosolic and nuclear compartments, the 
whole hippocampus was dissected on dry-ice using a tissue puncher (1 mm inner 
diameter) and tissue from two females of the same treatment and stress condition were 
119 
 
 
pooled together (n = 5 per group). Throughout the protein extraction procedure, samples 
were kept on ice or at 4˚C. An appropriate volume of cold S1 buffer (10mM HEPES pH 
7.5, 1.5mM MgCl2, 10mM KCl, 2mM DDT, 1mM EDTA, 1mM EGTA, 0.5% Triton-X) 
was added to the samples, which were homogenized in a Bullet Blender® and 
centrifuged (17,200 RCF for 3 min). The pellet was retained for preparation of the 
nuclear fraction, and the supernatant was collected and re-centrifuged (16,000 RCF for 20 
min) and the resulting supernatant was retained as the final cytosolic fraction. To wash 
the nuclear pellets, samples were re-suspended in the same volume of S1 buffer using a 
26.5-gauge needle, vortexed, and centrifuged (17,200 RCF for 3 min). The supernatant 
was discarded and the pellets were re-suspended and homogenized in ~1.2 pellet volumes 
of cold S2 buffer (20mM HEPES pH 7.5, 400mM NaCl, 1.5mM MgCl2, 0.1mM EDTA, 
20% glycerol, 2mM DTT), then incubated on ice for 1 hour during which time the 
samples were vortexed for 10 seconds every 10 minutes. After the incubation, the 
samples were centrifuged (17,200 RCF for 30 minutes) and the supernatant was retained 
as the final nuclear fraction. S1 and S2 buffer included a protease inhibitor cocktail 
(Sigma, 5892791001). Protein concentrations were determined for cytosolic and nuclear 
fractions using the Bio-Rad Protein Assay procedure (Bio-Rad) and a Biotech Synergy 
plate reader. Samples were brought to an equal concentration using the appropriate buffer 
and an equal volume of 2X Lammaeli buffer was added. Afterwards, samples were 
heated at 70˚C for 5 minutes, centrifuged (16,000 RCF for 10 min), and then stored at -
20˚C until Western blot experiments were conducted. 
Western blotting 
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To measure GR translocation, cytosolic and nuclear samples (30 µg of protein 
each) were resolved on 6% acrylamide gels and transferred to a PVDF membrane. Total 
protein was measured via Ponceau stain and used to normalize GR values. Membranes 
were reactivated, washed (3 X 5 min) in Tris-buffered saline with 1% Tween 20 (TBS-T), 
and blocked for 1 hour with 5% non-fat milk powder dissolved in TBS-T. Membranes 
incubated overnight at 4˚C in TBS-T containing 1% milk block and rabbit anti-GR (M20, 
Santa Cruz; 1:500 and 1:200 for cytosolic and nuclear samples, respectively). Next day, 
membranes were washed and then incubated for 45 minutes at room temperature in TBS-
T containing 1% milk block and goat anti-rabbit (Life Technologies, AlexaFluor 488; 
1:5000), washed again, and then were imaged using a Bio-Rad VersaDoc (MP 4000). 
Samples from each condition and stress condition (i.e., baseline or post-stress) were 
counterbalanced within and across gels. 
To validate the subcellular fractionation protocol, cytosolic and nuclear samples 
(10 µg of protein each) were resolved on a 12% acrylamide gels, blocked with 5% BSA, 
and probed with rabbit anti-histone H3 (D1H2; Cell Signaling; 1:1,000) and rabbit anti-
GAPDH (14C10; Cell Signaling; 1:1,000) in TBS-T with 1% BSA.  
Experiment 2: Effects of ovarian hormones on HPA responses and gene expression  
Animals 
Female Long-Evans rats (N = 48) were OVX by the supplier (Charles River) and 
arrived approximately 9 days later at P60 +/- 2 days. Rats were housed in same-treatment 
pairs (described below), kept on a 12-hour light-dark cycle (lights on at 0900), and were 
given free access to food and water. All procedures were in keeping with the National 
Institutes of Health Guide for Care and Use of Laboratory Animals (Publication No. 85-
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23, revised 1996) and the Canadian Council on Animal Care guidelines, and were 
approved by the Brock University Animal Care and Use Committee. 
Experimental manipulations and sample collection 
Seven days after the OVX females arrived, they were randomly assigned to one of 
three treatments (n = 16 per treatment), which involved four days of daily subcutaneous 
injections of vehicle (VEH), estradiol benzoate (EB), or EB and progesterone (EB+P); 
doses were the same as used in Experiment 1. Thus, females had been ovariectomized for 
20 days at the time of testing. Experiment 2 did not include non-OVX and OVX-
EB+P(FD) females, because these groups did not differ significantly from OVX-EB+P 
on corticosterone concentrations in Experiment 1. Injections before the test day were 
given during the lights on phase (between 1100 and 1700) and, on the day of testing, 
injections and sample collection occurred from 0800-0900 and from 1100-1400, 
respectively (stress started as early as 10:30). 
Half of the females in each treatment group were rapidly decapitated directly from 
the home cage (baseline) for the collection of trunk blood and brain tissue, as in 
Experiment 1. The other half of the animals underwent 30 minutes of restraint in 
Plexiglas® restrainers. Blood was collected from these females immediately (0 min), 45 
min, and 90 min after the 30 minutes of restraint stress ended (first two samples from the 
tail vein, 90 min sample from trunk blood; brains also collected); rats were returned to 
home cages between collections. The first tail vein sample (0 min post-stress) was 
obtained by nicking the end of the tail (~1-2 mm) using scissors, and the second sample 
(45 min post-stress) was obtained by dislodging the scab that formed after the tail nick 
(handling and collection of tail vein samples occurred within 2 minutes of removal from 
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the restrainer and the home-cage for the first and second post-stress collection time-
points, respectively). Blood was collected into ice-chilled tubes containing EDTA, 
centrifuged at 4˚C (3,000 RCF for 10 minutes), and plasma was stored until assayed (see 
methods Experiment 1). These time-points were selected based on previous evidence that 
adult OVX females have intermediate concentrations of corticosterone 45 minutes after 
termination of the stressor compared with baseline and post-stress concentrations, which 
reflects partial recovery at this time-point (Romeo et al., 2004). 
RT-qPCR 
 Approximately 6-8 punches (1 mm inner diameter) were collected on dry-ice 
from the ventral hippocampus and total RNA was extracted using a Fatty Tissue RNA 
Purification Kit (Norgen) as per kit instructions. RNA concentration and quality was 
assessed using a Nanodrop and sample (500 ng of RNA) were reverse transcribed using 
an iScript cDNA Synthesis Kit (Bio-Rad Laboratories). Primers were designed to 
measure mRNA expression for genes of interest (see Table 1). Samples were run in 
triplicate using a CFX Connect Real-Time System and SYBR green (Bio-Rad 
Laboratories) and were counterbalanced within and across plates. Gene expression was 
normalized to ubiquitin C (Ubc), hypoxanthine phosphoribosyltransferase 1 (Hprt1), and 
peptidylprolyl isomerase A (Ppia), which demonstrated good stability and did not differ 
based on stress condition or treatment. Three baseline (2 VEH, 1 EB) and three post-
stress (2 VEH, 1 EB) brains were compromised during collection and were thus excluded 
from the gene expression studies (resulting in n = 6-8 per group). 
Statistical analyses 
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For experiment 1, we used between-subjects (5 treatment x 2 stress condition) 
ANOVAs on concentrations of corticosterone and progesterone and on cytosolic and 
nuclear GR expression in the hippocampus. For experiment 2, between-subjects (3 
treatment x 2 stress condition) ANOVAs were used for hippocampal mRNA expression 
of various stress-related genes. Baseline corticosterone concentrations were analysed with 
a one-way (3 treatment) ANOVA. Post-restraint corticosterone concentrations were 
analysed with a mixed-model (3 treatment x 3 time-point) ANOVA. Significant 
interactions were followed up with simple effects analyses where appropriate and post-
hoc tests were Bonferroni-corrected with statistical significance set at p < 0.05. 
Results 
Experiment 1: Effects of ovarian hormones on HPA responses and GR translocation 
Corticosterone  
There was a significant effect of treatment (F4,90 = 4.7, p = 0.002) and stress (F1,90 
= 335.2, p < 0.0001) on corticosterone concentrations, and no interaction of the two 
factors (F4,90 = 1.4, p = 0.256). As expected, stress increased corticosterone across all 
treatments. Moreover, OVX-VEH females had lower concentrations of corticosterone 
compared with non-OVX females and with OVX-EB, OVX-EB+P, and OVX-EB+P(FD) 
females (all p < 0.05, see Fig. 1A). The lower corticosterone in OVX-VEH females was 
irrespective of stress condition and consistent with past evidence of a stimulatory effect 
of estradiol on baseline and post-stress concentrations.  
 Progesterone 
There was a main effect of treatment (F4,90 = 39.2, p < 0.001) and stress (F1,90 = 
55.0, p < 0.001) on progesterone concentrations, and an interaction between the two 
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factors (F4,90 = 2.5, p = 0.046). Follow up analyses indicated that concentrations of 
progesterone were lower at baseline compared with post-stress in all groups (all p < 
0.05), except for OVX-EB+P (p = 0.182). In baseline samples, non-OVX females had 
higher progesterone concentrations than did all other groups (all p < 0.05, see Fig. 1B) 
except OVX-EB+P (p = 0.999). Moreover, OVX-EB+P females did not differ from 
OVX-EB+P(FD) (p = 0.660), but they did have higher concentrations than OVX-EB (p = 
0.039) and OVX-VEH (p < 0.001) females. OVX-EB+P(FD) also had higher 
concentrations than did OVX-VEH females (p = 0.007), but did not differ from OVX-EB 
females (p = 0.999). For post-stress samples, the same treatment differences were 
observed as at baseline (all p < 0.05), except non-OVX females had higher concentrations 
of progesterone than did all other groups (all p < 0.05). 
GR translocation 
There was a significant effect of treatment (F4,38 = 3.2, p = 0.022) on cytosolic 
GR expression in the hippocampus, but no effect of stress (F1,38 = 1.2, p = 0.277), nor an 
interaction between the two factors (F4,38 = 1.7, p = 0.178). Post hoc tests indicated that 
OVX-VEH treated females had more cytosolic GR than OVX-EB and OVX-EB+P 
treated females (all p < 0.05; Fig. 1C). Although the omnibus interaction was not 
significant, likely because of reduced power from small group sizes (n = 4-5 per 
treatment and stress condition) and the 5 x 2 design, separate analyses for each stress 
condition suggested the effect of treatment was driven by differences at baseline (F4,19 = 
6.2, p = 0.002) rather than post-stress (F4,19 = 0.2, p = 0.941). Moreover, compared with 
baseline, stress decreased cytosolic GR in OVX-VEH females only (t8 = 2.7, p = 0.026). 
There was evidence of GR translocation in all groups on the basis of increased nuclear 
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GR expression in post-stress compared with baseline samples (main effect of stress, F1,38 
= 14.3, p = 0.001; see Fig. 1D). The effect of treatment (F4,38 = 0.3, p = 0.900) and the 
interaction of treatment and stress (F4,38 = 0.4, p = 0.832) were not significant. 
Experiment 2: Effects of ovarian hormones on HPA responses and gene expression  
Corticosterone 
 Although the pattern of differences paralleled those in experiment 1, the effect of 
treatment on corticosterone concentrations at baseline missed statistical significance 
(F2,21 = 2.7, p = 0.087). For post-stress samples, based on previous studies, we predicted 
that estradiol treatment would increase corticosterone concentrations in response to stress 
and would slow the recovery to baseline compared to vehicle treatment, and that 
progesterone would mitigate the effect of estradiol (Burgess & Handa, 1992; Viau & 
Meaney, 1991; Weiser & Handa, 2009). There was an effect of treatment (F2,21 = 5.8, p = 
0.01) and of time-point (F2,42 = 221.3, p < 0.0001) on corticosterone concentrations after 
restraint, as well as an interaction between the two factors (F4,42 = 9.6, p < 0.001). 
Follow-up analyses at each time-point indicated that at 0 min post-stress, OVX-VEH 
treated females had lower concentrations of corticosterone than did OVX-EB (p < 0.001) 
and OVX-EB+P (p = 0.034), and OVX-EB+P had lower concentrations than OVX-EB (p 
= 0.012; see Fig. 2). Thus, progesterone mitigated some of the stimulatory effects of EB. 
There was no effect of treatment at 45 or 90 min post-restraint (only the higher 
corticosterone 45 min after restraint in OVX-EB+P females compared with OVX-VEH 
females was marginally significant, p = 0.053). 
 Gene expression 
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 Contrary to our predictions, there was no effect of treatment on mRNA expression 
of Nr3c1 (GR), Nr3c2 (MR), Ncoa1 (SRC-1), Fkbp5, Fkbp4, or Bag1 (all p > 0.25; see 
Fig. 3). Moreover, treatment did not interact with stress on the expression of our genes of 
interest (all p > 0.5). There was, however, a higher expression of Fkbp5 post-stress 
compared with baseline that was irrespective of treatment (F2,36 = 4.8, p = 0.035; see Fig 
3D). 
Discussion 
We hypothesized that estradiol would increase HPA activity and that we would 
see a corresponding reduction in GR expression and activity, which we assessed by 
measuring cytosolic and nuclear GR in the hippocampus before and after acute restraint 
stress. Consistent with the literature (Handa & Weiser, 2014) and with our hypothesis, 
ovariectomy reduced baseline and post-stress concentrations of corticosterone relative to 
gonadally-intact females, and treatment of estradiol reversed the effect of ovariectomy. 
Moreover, ovariectomy increased cytosolic GR relative to several estradiol-treated 
groups, and this group was the only one to have a stress-induced decrease in cytosolic 
GR, which supported our hypothesis that estradiol restricts GR expression and activity. 
As expected, stress increased nuclear GR expression, but contrary to our hypothesis we 
did not see an effect of estradiol treatment. Therefore, we found partial evidence that 
estradiol reduces feedback by restricting GR expression and activity. Contrary to our 
hypotheses, there were no differences in the expression of genes that code for 
corticosteroid receptors or co-chaperones and co-activators known to modulate 
corticosteroid receptor activity. 
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Although this study and many others found that estradiol potentiated HPA 
activity, some studies have yielded contradictory results. For example, some reported no 
effect of estrous cycle phase on adrenocorticotropic hormones (ACTH) or on 
corticosterone concentrations after stress (Babb et al., 2013; Rivier, 1999). Others found 
that estradiol replacement had no effect (Serova et al., 2010) or reduced (Ferreira-Silva et 
al., 2009) concentrations of corticosterone in ovariectomized rats. The most conflicting 
results, however, are related to post-stress concentrations of ACTH, with a number of 
studies reporting increases (Burgess & Handa, 1992; Carey et al., 1995; Leśniewska et 
al., 1990; Seale et al., 2004b; Viau & Meaney, 1991; Weiser & Handa, 2009) and 
decreases (Babb et al., 2013; Figueiredo et al., 2007; Larkin et al., 2010; Redei et al., 
1994; Young et al., 2001) in rats given estradiol. Discrepancy in results may involve the 
time of sample collection after stress given that ACTH is released in pulses and is rapidly 
metabolized after its release (Reith & Neidle, 1981). Additional variability may stem 
from differences in the time between ovariectomy and treatment, as well as the dosage 
and duration of hormone treatment. For example, some studies administered estradiol at 
the time of surgery (Babb et al., 2013; Burgess & Handa, 1992; Seale et al., 2004b), 
whereas others waited until 6 weeks after ovariectomy (Redei et al., 1994). Further, some 
studies used doses that exceed those typically found in proestrus (Carey et al., 1995; Viau 
& Meaney, 1991) or utilized long treatment durations (Burgess & Handa, 1992). One 
strength of the current study is that we compared stress responses of gonadally-intact 
females with those of ovariectomized rats that received one of several ovarian 
replacement regimens, which were delivered over a brief period (4 days). Consistent with 
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the general literature, we found that estradiol increased the stress response whether it was 
administered daily or once only 48 hours before sample collection.  
 Actions of estradiol on HPA activity occur in the periphery as well as in the brain. 
Estradiol increases adrenal content and weight (Kitay, 1963; Leśniewska et al., 1990; 
Lunga & Herbert, 2004; McCormick et al., 2002) as well as adrenal sensitivity to ACTH 
(Atkinson & Waddell, 1997; Figueiredo et al., 2007). Stimulatory effects of estradiol on 
HPA function are observed when administered to the PVN (Liu et al., 2012; Weiser & 
Handa, 2009) or to the medial preoptic area (McCormick et al., 2002). When selective 
estrogen receptor agonists were administered to the paraventricular nucleus (PVN) of the 
hypothalamus, ERα agonists increased, whereas ERβ agonists decreased, HPA activity 
(Liu et al., 2012; Weiser & Handa, 2009). Thus, the stimulatory effects of estradiol on 
HPA activity seem to be mediated by ERα, possibly in GABAergic neurons of the peri-
PVN (given that the parvocellular portion is virtually devoid of ERα (Handa & Weiser, 
2014; Miller et al., 2004) and in upstream brain regions. 
 In addition to potentiating HPA activity, there are many reports that estradiol 
impaired negative feedback as evidenced by delayed recovery after stress and reduced 
suppression of corticosterone after treatment with a GR agonist (Burgess & Handa, 1992; 
Carey et al., 1995; Viau & Meaney, 1991; Weiser & Handa, 2009). Estradiol’s 
dampening of HPA feedback also appears to be mediated by ERα, at least near the PVN, 
and occurs at baseline and after stress (Weiser & Handa, 2009), which means that the 
stimulatory effects of estradiol in the brain may involve reduced suppression rather than 
enhanced drive. Little is known, however, regarding the downstream mechanisms of 
estradiol-induced suppression or its actions in other brain regions important for negative 
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feedback, but changes in corticosteroid receptors or their activity may be involved. 
Surprisingly, we found no evidence of estradiol-induced suppression of HPA feedback in 
the current study, perhaps because samples were obtained at 45 minutes; at an earlier 
recovery time-point, differences may have emerged. We did, however, find that 
ovariectomy increased the expression of cytosolic GR in the hippocampus, which may 
allow for more GR-mediated feedback. The greater baseline densities of cytosolic GR in 
the hippocampus may be because of the lower baseline corticosterone concentrations in 
the ovariectomized, non-replaced females compared with the other groups. Although one 
study showed a trend for ovariectomy to increase GR binding capacity for corticosterone 
in the hippocampus (Turner & Weaver, 1985), others found no effect of estradiol on 
binding capacity for GR agonists (Burgess & Handa, 1992; Ferrini & de Nicola, 1991).  
 Reports that ovariectomy increased nuclear GR (Sheng et al., 2003) and that 
estradiol treatment produced an anti-translocation profile of co-chaperones in cell culture 
(Malviya et al., 2013) led us to investigate GR translocation. Consistent with our 
predictions, only the ovariectomized, non-replaced group showed a stress-induced 
reduction of cytosolic GR in the hippocampus, which suggests that estradiol may restrict 
GR translocation. Thus, when we examined nuclear GR, we expected to find a 
concomitant increase in stress-induced translocation in ovariectomized, non-replaced 
females compared with the other conditions, but the results indicated a similar change 
across groups. One possible explanation for why ovariectomized females had greater 
stress-induced GR translocation than the other groups based on differences in the cytosol 
and not in the nucleus is that ovariectomy may have promoted GR trafficking to other 
cellular compartments (e.g., the cell membrane). Although corticosterone treatment 
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increased membrane-bound GR in a hypothalamic cell line (Deng et al., 2015), it is 
unclear what role estradiol plays, if any, in affecting GR trafficking to the membrane. 
Another possibility is that our experiment was sensitive to detect group differences in 
stress-induced changes in the cytosol and not in the nucleus because GR is predominantly 
located in the nucleus even at baseline (Sheng et al., 2003). Nevertheless, our study 
seems to be the first to examine estradiol’s effect on GR translocation following acute 
challenge in vivo, but our translocation experiment involved small group sizes and as 
such warrants replication.  
 Estradiol’s actions on HPA stress responses may involve mineralocorticoid 
receptors (MR); for example, one study found that estradiol reduced MR’s binding 
capacity (Carey et al., 1995). Unlike GR, however, MR are mostly bound under basal 
conditions and thus we did not expect to see prominent stress-induced changes in MR 
that would be affected by gonadal hormones. Moreover, others have found more evidence 
for actions of estradiol on GR than on MR (Burgess & Handa, 1992, 1993). It would be 
worthwhile, however, to investigate phosphorylation of corticosteroid receptors, which 
can induce translocation and increase transcriptional activity in the absence of ligand-
binding (Hapgood et al., 2016). In support of this, a previous study found that estradiol 
dephosphorylates GR in breast cancer cell lines (Zhang et al., 2009). Therefore, it is 
unclear whether the stress-induced decrease in cytosolic GR in ovariectomized, non-
replaced females reflects greater receptor binding, phosphorylation, or both. Given that 
ovariectomized females also released less corticosterone than gonadally-intact females 
and ovariectomized females treated with estradiol alone or in combination with 
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progesterone, we may have seen a bigger difference had they been treated with a 
comparable dose of corticosterone.   
 Based on the greater amount of GR protein in the hippocampus of 
ovariectomized, non-replaced rats relative to other groups, we expected to see a 
concomitant increase in corticosteroid receptor mRNA at baseline relative to estradiol 
replaced rats. Nevertheless, there were no group differences in either GR or MR mRNA 
expression at baseline. Previous studies have yielded mixed results with some finding 
that estradiol treatment reduced MR, but not GR, in the hippocampus (Carey et al., 1995; 
Peiffer et al., 1991) and others finding a decrease in both MR and GR (Burgess & Handa, 
1993). Moreover, one study found that, relative to sham-operated controls, ovariectomy 
reduced GR, but not MR, mRNA in the hippocampus (Patchev & Almeida, 1996). 
Therefore, effects of ovariectomy and of estradiol replacement on corticosteroid receptor 
transcript remain inconsistent and may not be a good measure for actions on receptor 
protein levels or activity.  
 The decrease in cytosolic GR post-stress compared with baseline in 
ovariectomized females, which we interpreted as evidence of translocation, was not 
accompanied by differences in baseline mRNA expression of co-chaperones (Fkbp5, 
Fkbp4, Bag1) that are known to modulate GR assembly and trafficking. This lack of 
difference contradicts previous work in hippocampal cell culture that found estradiol 
produced a GR anti-translocation profile of gene expression (Malviya et al., 2013). Thus, 
more investigation of protein expression of co-chaperones and their interactions with 
corticosteroid receptors in vivo is required to elucidate their role, if any, on receptor 
dynamics and negative feedback. Surprisingly, we did not find that estradiol altered the 
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effect of acute stress on the expression of any of the genes we investigated. This result 
conflicts with a previous report that estradiol prevented the reduction in hippocampal GR 
mRNA and protein (as evidenced by binding assay, which could reflect receptor densities 
and/or changes in their affinity for agonists) that was found in ovariectomized, non-
replaced females treated with a GR agonist (Burgess & Handa, 1992, 1993). Although 
estradiol has been shown to alter the expression of the steroid receptor co-activator, 
Ncoa1 (SRC-1), in a region-specific manner (Mitev et al., 2003), we did not observe any 
group differences, consistent with a previous study showing that ovariectomy did not 
affect its expression in the hippocampus (Zhang et al., 2011).  
 Although the effects of ovariectomy are attributed to the reduction of circulating 
estradiol in females, progesterone is also released from the ovaries and may mitigate 
some of the effects of estradiol on HPA activity (Viau & Meaney, 1991) or have 
suppressing actions on its own (Figueiredo et al., 2007). Therefore, we examined the 
effects of progesterone co-treatment with estradiol compared with those that received no 
replacement or estradiol alone. The results from experiment 2 supported past reports that 
progesterone partially mitigates estradiol’s stimulatory effects. In experiment 1, however, 
progesterone co-treatment had no effect. Others found that progesterone had no effect on 
HPA responses to stress (Ferreira-Silva et al., 2009; Young et al., 2001). Thus, it remains 
unclear whether progesterone treatment buffers the stress response in females and, if so, 
what mechanisms are involved. One study found that, in adrenalectomized and 
ovariectomized females given corticosterone replacement, progesterone treatment 
increased GR mRNA in the hippocampus, which may promote negative feedback 
(Patchev & Almeida, 1996).  In the current study, however, progesterone did not alter GR 
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mRNA or protein in this region. We did find, however, that stress increased the release of 
progesterone, which is consistent with other studies (Kalil et al., 2013; Simone & 
McCormick, 2017). Moreover, although the difference was not significant (likely because 
of the number of comparisons), estradiol treatment tended to increase progesterone 
concentrations relative to ovariectomized females without estradiol, possibly by 
enhancing synthesis and decreasing degradation (Munabi et al., 1983). Thus, estradiol-
induced increases in progesterone may mitigate the direct stimulatory effects of estradiol 
in gonadally-intact females. Others, however, have found no effect of ovariectomy or 
estradiol replacement on progesterone release (Kalil et al., 2013). 
 In summary, our results show that as little as one administration of estradiol 48 h 
before sample collection can increase stress-induced corticosterone release. Although we 
provide evidence that ovariectomy increases the amount of cytosolic GR receptors, we 
found no effect of ovariectomy or of ovarian hormone replacement on changes in nuclear 
GR expression in response to an acute stressor or on mRNA expression of co-chaperones 
that are known to modulate ligand binding and receptor trafficking within the 
hippocampus. Although estradiol’s effects on increasing corticosterone release are 
attributable to actions at ERα (Liu et al., 2012; Weiser & Handa, 2009), the downstream 
mechanisms for the effects on stress-induced increases and recovery remain to be 
elucidated. 
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Tables 
Table 4-1. Sequences of primers used in RT-qPCR reactions. 
Gene Forward Reverse 
Nr3c1 (GR) GTGCTACCCCGACAGAGAAG CCGCCAAAGGAGAAAGCAAG 
Nr3c2 (MR) CAGCTCACCTCCATTACGCA CTTCACGACCTGGCTCATCT 
Fkbp5 TTCCCTCGAACGCAACTCTC GTCGTGGTCTTCTCCTTCGC 
Fkbp4 GAAGTCGGGGAAGGGGAAAG GCATGTGGTGGGATCTGGAA 
Bag1 TAGCGGAAGAGGTGACCCAG CTCCTGTGGCCTCTTCAACA 
Ncoa1 (SRC-1) CAGTGGCAAAGATGAGACG CGAGTATGGCTGGGGATAG 
Hprt1 CAGACTTTGCTTTCCTTGG CCGCTGTCTTTTAGGCTTTG 
Ubc CCAAGAAGGTCAAACAGG GACACCTCCCCATCAAAC 
Ppia CCGCTGTCTCTTTTCGCC ATCCTTTCTCCCCAGTGCTC 
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Figures 
 
Figure 4-1. Mean (± S.E.M.) plasma concentrations of (A) corticosterone and (B) 
progesterone and of hippocampal expression of GR in the (C) cytosol and (D) nucleus at 
baseline (light-grey bars) or post-stress (dark-grey bars) in gonadally-intact (non-
ovariectomized [OVX]) females and in OVX females from different treatment groups; 
OVX females received four daily injections of either vehicle (VEH), estradiol benzoate 
(EB), EB and progesterone (EB+P), or EB+P (FD; fewer doses), which was done to 
mimic release in naturally cycling females. (A) & indicates lower than all other treatment 
groups irrespective of stress condition (all p < 0.05 for OVX-VEH compared with all 
other groups). (B) grey symbols are used for within baseline comparisons of treatment 
effects and black symbols are used for post-stress comparisons of treatment effects; * 
indicates when lower than non-OVX females; @ indicates when higher from OVX-VEH 
female; # indicates when higher than OVX-EB females (only statistically significant 
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groups differences are pointed out, all p < 0.05). (C) ^ indicates a significant difference 
between baseline and post-stress within a treatment group (p = 0.026), and the lines 
above bars indicate differences between OVX-VEH and OVX-EB or OVX-EB+P (all p < 
0.05). (D) + indicates an effect of stress irrespective of treatment group (p = 0.001).  
137 
 
 
 
Figure 4-2. Mean (± S.E.M.) plasma concentrations of corticosterone collected straight 
from the home-cage (baseline) or from repeated sampling taken at 0, 45, and 90 minutes 
after 30 minutes of restraint stress in ovariectomized (OVX) females from different 
treatment groups; OVX females received four daily injections of vehicle (VEH), estradiol 
benzoate (EB), or EB and progesterone (EB+P). * indicates a significant effect of 
treatment within that time-point and the bars indicate which groups differ; at 0 mins post-
stress, OVX-VEH had lower concentrations than OVX-EB+P (p = 0.034) and OVX-EB 
(p < 0.001), and OVX-EB+P had lower concentrations than OVX-EB (p = 0.012). 
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Figure 4-3. Relative mRNA expression (S.E.M.) of Nr3c1 (A), Nr3c2 (B), Ncoa1 (C), 
Fkbp5 (D), Fkbp4 (E), and Bag1 (F) at baseline (light-grey bars) and 90 minutes after 30 
minutes of restraint stress (post-stress) with 1.0 set to OVX-VEH at baseline. * indicates 
a significant effect of time-point. 
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Chapter 5: General Discussion and Conclusions 
Summary of thesis findings and their contribution to the field of 
neuroendocrinology 
 The overarching goals of this thesis were to examine developmental shifts in HPA 
function and its regulation by gonadal hormones, and to investigate the mechanisms 
underlying these changes. In Chapter 2, I provided evidence of developmental shifts in 
the hormonal profile (testosterone, corticosterone, and progesterone) of intact male rats 
during the adolescent period. Pre-pubertal adolescent (P35) males had lower basal 
concentrations of testosterone compared with post-pubertal adolescent (P45) and adult 
males (P75) and, after acute stress, concentrations decreased in the adolescent groups and 
increased in adults, indicating developmental changes in gonadal regulation by stressors 
between puberty and adulthood (see Fig. 2-1A). The stress-induced decrease and increase 
of testosterone in adolescent and adult males, respectively, has been reported elsewhere 
(Foilb, Lui, & Romeo, 2011; Gomez, Houshyar, & Dallman, 2002; Romeo, Lee, Chhua, 
McPherson, & McEwen, 2004).  
Consistent with previous studies (Klein & Romeo, 2013; Romeo, 2010; Romeo, 
Bellani, & McEwen, 2005), I found that pre-pubertal adolescents released more 
corticosterone and progesterone in response to acute stress compared with adult males 
(see Fig. 2-1B/C). Post-pubertal adolescents, for which there are fewer investigations, 
also had greater stress-induced release of progesterone compared with adults, but did not 
differ in corticosterone (concentrations were intermediate to that in pre-pubertal 
adolescents and adults). Therefore, there may be age-related changes in enzymes 
involved in adrenal hormone synthesis that restricts corticosterone production and bias 
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precursors (e.g., progesterone) during the post-pubertal period. Nevertheless, there was a 
trend for greater release of corticosterone at P45 than at P75, which is consistent with 
reports that HPA responses continue to mature between P40 and P60 (Foilb et al., 2011; 
Gomez et al., 2002). I have also shown that post-stress concentrations of progesterone 
and corticosterone were correlated in all age groups examined (see Fig. 2-1D), which has 
been previously reported in adults (Hueston & Deak, 2014), and likely reflects individual 
differences in general adrenocortical output. 
The pronounced HPA response in adolescence can be attributed to differences at 
each level of the axis (Klein & Romeo, 2013), and likely reflects greater drive and 
reduced negative feedback. Protracted release of ACTH and corticosterone in response to 
stress points to negative feedback as a basis for age-related differences, and is not likely 
related to steroid metabolism (Schapiro, Percin, & Kotichas, 1971; Vazquez, 1998) or to 
circulating CBG concentrations (Romeo et al., 2006). Consistent with the idea that 
feedback is maturing in adolescence, GR agonists were less effective at suppressing HPA 
responses in pre-pubertal adolescents compared with adults (Goldman, Winget, 
Hollingshead, & Levine, 1973; Vazquez & Akil, 1993). Other studies had investigated 
GR protein and mRNA expression as a source for age-related differences and found little 
to no change in stress-related brain regions (e.g., PVN, pituitary, hippocampus, mPFC) 
(Dziedzic, Ho, Adabi, Foilb, & Romeo, 2014; Romeo, 2013; Romeo et al., 2008; 
Vazquez, 1998). Nevertheless, there may be age-related differences in GR’s affinity for 
corticosterone or its activity when bound that mediates poor negative feedback in pre-
pubertal adolescents.  
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In Chapter 2, I investigated GR expression in the cytosolic and nuclear 
compartments of hippocampal tissue at baseline and after stress as a proxy for 
translocation. The hippocampus was selected based on its rich expression of GR and 
because it is a major forebrain region involved in negative feedback (Herman, McKlveen, 
Solomon, Carvalho-Netto, & Myers, 2012; Mizoguchi et al., 2009). I also measured gene 
expression of corticosteroid receptors (Nr3c1, Nr3c2) and of co-chaperones (Fkbp5, 
Fkbp4, Bag1) that modulate steroid receptor activity. Consistent with previous studies in 
rats and mice (Dziedzic et al., 2014; Romeo, Kaplowitz, Ho, & Franco, 2013), I found 
that baseline expression of hippocampal GR (cytosolic + nuclear) was similar across age 
groups (see Fig. 2-2A-2E), although others have reported a decrease between P35 and 
~P100 (Meaney, Sapolsky, & McEwen, 1985). In rats that underwent restraint stress, 
cytosolic GR decreased and nuclear GR increased and the change was more pronounced 
at P35 than at P75, providing novel evidence that GR translocation in the hippocampus is 
not blunted during adolescence and thus, is not a basis for immature feedback. Greater 
GR translocation in pre-pubertal males was likely because of their greater release of 
corticosterone in response to stress or because they had elevated expression of Fkbp4 
mRNA compared with adults (Fkbp4 codes for the GR pro-translocation co-chaperone, 
Fkbp52) (see Fig. 2-1C and 2-4D).  
After 30 minutes of recovery from restraint stress, pre-pubertal adolescents had 
greater GR expression (cytosolic and nuclear) than did adults, but because we could not 
compare this time-point with earlier ones, it is unclear whether the age-related difference 
reflects greater synthesis in adolescents, degradation in adults, or both. Because GR is 
auto-regulated (glucocorticoids suppress their own receptor targets) via hyper-
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phosphorylation-induced ubiquitination and proteasomal degradation (Vandevyver, 
Dejager, & Libert, 2012) and via decreased mRNA expression (Burgess & Handa, 1993; 
Romeo et al., 2008), greater degradation in adulthood than in adolescence is a more likely 
a source for age-related differences. However, others have reported no change in total GR 
protein in pre-pubertal adolescents and adults 30 minutes after stress, relative to baseline 
(Dziedzic et al., 2014), and a comparable decrease in GR was observed after 5 days of 
corticosterone treatment (Meaney et al., 1985). An alternative explanation is that GR may 
have been preferentially trafficked to another cellular compartment (e.g., the cell 
membrane) in adults relative to pre-pubertal adolescents, but as we only examined 
cytosolic and nuclear expression, this remains unknown. 
I found no age-related differences in the mRNA expression of corticosteroid 
receptors (Nr3c1 and Nr3c2) or of the other co-chaperones examined (Fkbp5 and Bag1) 
(see Fig. 2-4). Consistent with a previous study (Romeo et al., 2008), stress reduced 
Nr3c1 (GR) mRNA expression in adolescent and adult males to the same extent, despite 
age-related differences in stress-induced release of corticosterone as well as in GR 
translocaton (as shown in the present study). These finding suggests a dissociation 
between the magnitude of an HPA response and the downstream changes in gene 
transcription. Another dissociation between stress response and changes in gene 
expression was also observed in the present study for the expression of Fkbp5 mRNA, 
which was up-regulated after stress to a similar extent in all age groups. An avenue for 
future research will be to examine age-related differences in the regulation of gene 
expression (e.g., chromatin remodelling, expression of co-factors, activators, and 
repressors) after stress or corticosterone treatment, as the basis for the dissociation.  
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 In Chapter 3, I investigated whether age-related differences in circulating 
concentrations of testosterone account for differential corticosterone responses to acute 
stress; in adult males testosterone reduces HPA activation and facilitates a return to basal 
titers (Goel, Workman, Lee, Innala, & Viau, 2014). I have provided evidence that age-
related differences in HPA responses to acute stress persist when males of each age are 
OCX and given a comaparable dose of testosterone, consistent with the results of a 
previous study (Romeo, Lee, Chhua, et al., 2004). Additionally, I have shown that the 
effect of testosterone on stress-induced corticosterone release changes during 
adolescence, and provide evidence of developmental shifts in reactivity during the post-
pubertal period that depends on the presence of testosterone. Specifically, testosterone 
had no effect on corticosterone release at P35, increased concentrations of corticosterone 
at P45, and tended to reduce concentrations at P75 (see Fig. 3-2C, middle panel). 
Moreover, in OCX males that received testosterone, corticosterone responses were more 
pronounced at P35 and P45 than at P75, whereas in those that did not get testosterone, 
P35 males responded more strongly than did P45 and P75 males. Together, these findings 
reveal developmental shifts in HPA function and its regulation by gonadal hormones. 
Stress increased Fos expression in the PVN, which was used as a marker of 
neuronal activation (see Fig. 3-3D). There was nearly an effect of age (p = 0.064), which 
would be consistent with previous studies showing greater expression of Fos in the PVN 
of pre-pubertal adolescents compared with adults (Lui et al., 2012; Novak, Parfitt, Sisk, 
& Smale, 2007; Romeo et al., 2006; Viau, Bingham, Davis, Lee, & Wong, 2005). There 
was no effect of testosterone on Fos expression, however, which was expected in adults 
based on previous studies showing an androgen-induced decrease in its protein and 
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transcript expression (Lund, Hinds, & Handa, 2006; Lund, Munson, Haldy, & Handa, 
2004; Viau, Lee, Sampson, & Wu, 2003; Williamson, Bingham, Gray, Innala, & Viau, 
2010). 
When the HPA axis is activated, AVP is released alongside CRF from neurons 
that originate in the medial parvocellular PVN and project to the median eminence. I 
measured AVP expression in the PVN based on previous evidence for androgen-induced 
suppresion of its mRNA or peptide expression (Evuarherhe, Leggett, Waite, Kershaw, 
Atkinson, et al., 2009; Seale, Wood, Atkinson, Harbuz, & Lightman, 2004; Viau et al., 
2003; Viau & Meaney, 1996). Consistent with the literature, testosterone reduced AVP, 
and the effect was present before and after stress and in all age groups (see Fig. 3-3E). 
These findings indicate that pre-pubertal adolescent males are responsive to androgenic 
actions in the PVN, despite testosterone not affecting post-stress concentrations of 
corticosterone at this age. These findings also indicate that the age-related differences in 
the effect of testosterone on stress-induced release of corticosterone do not involve 
differences in AVP production. 
Instead, I predicted that age-related differences in testosterone’s regulation of 
corticosterone release may involve differences in testosterone’s conversion to various 
metabolites, and I attempted to answer this using AR and ER antagonists in the presence 
of testosterone or DHT. The results indicated a similar, albeit non-significant, pattern of 
results to what we found in experiment 1 (see Fig. 3-2C, middle panel, and Fig. 3-5A), 
but no significant effects involving age, DHT treatment, or receptor antagonists on post-
stress concentrations of corticosterone. The lack of an age-related difference conflicts 
with findings from Chapter 2 and Chapter 3 (experiment 1) and may reflect the fact that 
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experiment 2 invovled repeated injections prior to acute stress and plasma collection. The 
lack of an effect is not likely related to ineffective androgen implants because both 
testosterone and DHT reduced post-stress concentrations of progesterone, an effect that 
was reversed by the AR antagonist flutamide (see Fig. 3-5C and 3-5D). Therefore, I 
hypothesized that different findings in experiment 2 may relate to the stressful nature of 
our manipulations prior to measuring stress reactivity. Age-related differences in HPA 
function have been examined in response to a homotypic and heterotypic stress (Lui et 
al., 2012; Romeo et al., 2006; Romeo, Karatsoreos, Jasnow, & McEwen, 2007), but how 
stress history modulates the effect of gonadal hormones on HPA function requires 
invetigation.  
 In Chapter 4, I examined ovarian hormone regulation of HPA function in adult 
females. Although several studies have examined developmental shifts in ovarian 
regulation of HPA function during adolescence (Evuarherhe, Leggett, Waite, Kershaw, & 
Lightman, 2009; Romeo, Lee, & McEwen, 2004), the mechanisms remain unclear, and 
investigations in adults may provide insights necessary to understanding age-related 
differences.  I have shown that OVX dampens the corticosterone response to stress 
compared with the response in gonadally-intact females, and that estradiol administered 
alone or in combination with progesterone potentiated the response to that in gonadally-
intact females (see Fig. 4-1A). These findings are consistent with the majority of studies 
that investigated ovarian hormones regulation of HPA function (Green & McCormick, 
2016; Handa & Weiser, 2014). I also investigated GR translocation in the hippocampus 
based on previous reports that estradiol impedes negative feedback (Burgess & Handa, 
1992; Carey, Deterd, de Koning, Helmerhorst, & de Kloet, 1995; Viau & Meaney, 1991; 
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Weiser & Handa, 2009) and found that OVX increased the expression of cytosolic GR 
relative to other groups, which may be a basis for blunted feedback in estradiol treated 
females (see Fig. 4-1C). In experiment 2, I replicated the stimulatory effect of estradiol 
on corticosterone release, but when I examined corticosterone recovery 45 and 90 
minutes after restraint stress all groups had approached baseline concentrations, which 
means I did not see evidence of delated recovery (see Fig. 4-2). Progesterone partially 
mitigated the effect of estradiol, which is consistent with a previous report (Viau & 
Meaney, 1991), but conflicts with the lack of an effect reported by others (Ferreira-Silva, 
Helena, Franci, Lucion, & Anselmo-Franci, 2009; Young, Altemus, Parkinson, & 
Shastry, 2001) and with results of experiment 1, which involved only one post-stress 
time-point. 
 Estradiol has been reported to modulate mRNA of corticosteroid receptors and 
co-activators in vivo (Burgess & Handa, 1993; Mitev, Wolf, Almeida, & Patchev, 2003) 
and co-chaperones in vitro (Malviya et al., 2013), which led us to investigate their 
expression along side GR translocation. I found no evidence for estradiol-induced 
changes in mRNA expression for any of our genes of interest (see Fig. 4-3). I did, 
however, find that stress increased Fkbp5 expression regardless of treatment in females, 
just as it did for males of different ages in Chapter 2. Together, these findings indicate 
that OVX reduces HPA function, which may involve greater inhibitory tone by 
increasing the availability of GR protein.  
Implications and outstanding questions  
Studies included in this thesis have contributed to the field by replicating and 
expanding past findings regarding developmental shifts in HPA function and its 
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regulation by gonadal hormones during adolescence and early adulthood. Nevertheless, 
the mechanisms that govern some of the changes remain unclear and require future 
investigation. The studies contained in this thesis and answers to oustanding questions 
that are proposed below are important because they can enhance our understanding of 
factors that drive adolescent development, and that allow for long-term organization of 
cognition, affect, and behaviour by environmental influences during this time. 
Adolescence is a transitional period between childhood and adulthood that is 
characterized by changes in cognition and behaviours, such as increased exploration, 
risk-taking, and emphasis on peer relationships (McCormick, Mathews, Thomas, & 
Waters, 2010; Schulz & Sisk 2016). These changes reflect maturation of underlying 
neural circuits and in the hormonal milieu (e.g., HPA and HPG output) during this time. 
The reorganization and fine tuning of these circuits that occurs in preparation for 
adulthood is made possible by heightened plasticity, which also renders adolescents 
vulnerable to insults (McCormick et al., 2010). Consistent with this notion, chronic stress 
during adolescence has long-lasting effects on cognition, mood, endocrine function, and 
social behaviour that are observable in adulthood (Green, Barnes, & McCormick, 2013; 
Green & McCormick, 2013; McCormick & Green, 2013).  
Greater activation of the HPA axis in response to stress during adolescence may 
also explain why this age group is more sensitive to the programming effects of stress 
compared with adults, but more research is needed to tease apart the source of adolescent 
vulnerability. In Chapter 2, I report that GR translocation in response to stress was greater 
in pre-pubertal adolescents compared with adults, which corresponded with their greater 
release of corticosterone and expression of Fkbp4 mRNA. Although it was meaningful to 
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examine age-related differences in GR translocation in vivo, and in response to a 
perceived stressor, it would be worthwhile to examine age-related differences in 
translocation when corticosterone concentrations are held constant. This constancy could 
be accomplished by adrenalectomy and systemic or central administration of 
corticosterone and would have the advantage of identifying developmental changes in 
stress signaling under constant conditions. Moreover, future studies should investigate 
differences in gene expression in males from each age group that are given a comparable 
dose of corticosterone that mimics stressful conditions. The studies proposed above may 
uncover age-related differences in stress signaling and may identify targets of stress that 
are differentially regulated as a function of age, both of which could underscore 
adolescent vulnerability.  
Age-related differences in progesterone release after stress, which were presented 
in Chapter 2 and elsewhere (Romeo et al., 2005), suggest that progesterone should also 
be held constant when examining developmental shifts in HPA function (e.g., PVN 
activation and ACTH release) and gene transcription; progesterone may also contribute to 
the reduction in HPA function after a stressor exposure (Hueston & Deak, 2014). Such 
investigations may provide insight into how progesterone modulates HPA function and 
reveal mechanisms underlying developmental shifts in the response to acute and chronic 
progesterone exposure. 
A related question that remains is, are there advantages to having a pronounced 
and prolonged stress response during adolescence, provided that the HPA axis is not 
activated too often or in relation to a traumatic event? During the stress-hyporesponsive 
period, which in rats occurs during the first two weeks of life, HPA responses to stressors 
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are blunted, presumably to protect the brain from insult during a period of rapid 
development (Meaney, Sapolsky, & McEwen, 1985; Naninck, Lucassen, & Bakker, 
2011). Adolescence, which is also a sensitive period of development, however, involves 
pronounced HPA responses to challenges. One explanation is that greater HPA responses 
during adolescence may help to consolidate emotionally-salient events (Barbayannis et 
al., 2017), which may prepare adolescents for adulthood by shaping expectations for 
related-outcomes and coping strategies in the face of future challenges. Therefore, 
advancing our understanding of factors that promote vulnerability during adolescence 
may concomitantly elucidate the mechanisms that promote adaptive maturation of 
function, and refine how we think about adolescent development in general. 
 Advancing our understanding of adolescent development and how the brain 
responds to stressors during this time could also provide insight into the etiology of 
various psychopathologies (e.g., anxiety and depression), which tend to emerge during 
adolescence (Altemus, Sarvaiya, & Epperson, 2014). Psychopathologies tend to be 
associated with a history of stressful experiences and those afflicted typically have HPA 
dysregulation. For example, individuals that suffer from depression typically have 
elevated concentrations of resting cortisol and blunted HPA feedback (Naninck, 
Lucassen, & Bakker, 2011). Evidence from animal models indicates that chronic stress 
experienced in adolescence causes an increase in depressive and anxiety-like behaviour 
in adulthood (McCormick & Green, 2013), which suggests that the association in humans 
is not explained by a greater tendency to report stressful events by depressed individuals. 
Therefore, investigations into maturation of HPA function in adolescence may provide 
insight into mechanisms related to psychopathology as well as potential therapeutic 
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targets. Moreover, because there are well-documented sex differences in the prevalence 
and symptom severity of psychopathologies (women are approximately twice as likely to 
suffer from depression than are men) that emerge during adolescence (Naninck et al., 
2011), investigations into HPA and HPG interactions may also elucidate targets.  
We have provided evidence for developmental shifts in gonadal regulation of 
HPA function in adolescence and shown that pre-pubertal adolescents are sensitive to 
androgens, as evidenced by reduced AVP expression in the PVN. These findings indicate 
that testosterone’s actions depend on the developmental context, and challenge the notion 
that pre-pubertal animals are unresponsive to gonadal hormones. Therefore, the pre-
pubertal brain may already be capable of being organized by gonadal hormones, and 
consistent with this notion, evidence in hamsters shows that testosterone can masculinize 
reproductive behaviour before adolescence (Schulz & Sisk, 2016). Thus, maturation of 
HPG function at puberty and the greater conversion of testosterone to estradiol at this 
time likely dictates when the second window for gonadal organization occurs (perinatal 
being the first). A consequence of the greater conversion of testosterone to estradiol in 
the post-pubertal adolescents may be a pronounced response to stressors.   
Although pre-pubertal males do not have adult-like levels of androgens, 
investigations into gonadal regulation of HPA function during this time will likely 
advance our understanding of adolescent development. Future studies are needed to 
elucidate the underlying mechanisms governing age-related changes in HPG regulation of 
HPA function remain unclear. The contribution of potential receptor targets of gonadal 
hormone metabolites on HPA function should be investigated based on evidence for 
changing enzyme expression in adolescence (Lephart & Ojeda, 1990); I attempted to do 
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this in Chapter 3, but saw little evidence for changes in corticosterone release. 
Nevertheless, this is only the first study to examine the effects of testosterone on HPA 
function in adolescence, as well as the receptors mediating testosterone’s actions; others 
have characterized targets for gonadal regulation in adulthood (Handa & Weiser, 2014; 
Lund et al., 2006). Additionally, I only examined concentrations of corticosterone and 
progesterone at one post-stress time-point, and differences are likely to present in other 
HPA related measures or in the input from upstream regions (e.g., peri-PVN, BNST, 
mPOA, and hippocampus).  
A limitation of the study that examined receptor targets for testosterone (and 
potential metabolites) was the stressful nature of our manipulations. Nevertheless, 
research into the effect of gonadal regulation of chronic stress responses is particularly 
important for understanding stress-related psychopathologies and provides greater 
translational relevance for humans; the human stress response is initiated in the context of 
a life-time of prior exposure to stressful events. Moreover, it is worth understanding how 
chronic stress regulates gonadal status across development; myself and others (Foilb et 
al., 2011) have shown that acute stress suppresses testosterone release in adolescents and 
increases its release in adults. In adults, repeated exposure to stress suppresses gonadal 
function, but only a couple studies have examined the effects of chronic stress on gonadal 
function in adolescents and adults (Gomez et al., 2002; Gomez, Manalo, & Dallman, 
2004). Many studies have examined the effects of chronic stress in adolescence on adult 
measures of social behaviour, learning and memory, and mood (Green & McCormick, 
2013; McCormick & Green, 2013), but it remains unclear whether adolescent sensitivity 
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is driven directly by stress or indirectly via changes in gonadal hormones that could 
disrupt adolescent development.  
Answers to the above questions, coupled with the findings contained in this thesis, 
will enhance our understanding of adolescent development and neuroendocrine function.  
Moreover, because of the pleiotropic effects of glucocorticoid signaling and its 
involvement in health, these investigations may provide insight into the mechanisms that 
underlie dysfunction related to psychopathologies (e.g., anxiety and depression) and 
elucidate markers of vulnerability. In Chapter 4, I investigated gonadal regulation of HPA 
function in adult females to lay the groundwork for future investigations into the 
mechanisms underlying female maturation of HPA during adolescence. Studies on 
female rodents are critically important because the majority of research on HPA 
maturation has been conducted on males, and because sex differences often emerge. 
Lastly, although investigations in rodents do not always translate to humans, they are 
essential for understanding the principles that govern neuroendocrine function and how it 
changes across development, and provide a framework as well as targets for studies in 
humans, which are currently lacking. 
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